%PDF-1.6
%
1 0 obj
<>
endobj
2 0 obj
<>stream
Maria Helde-Frankling, Jonas Höijer, Jenny Bergqvist, Linda Björkhem-Bergman
Vitamin D supplementation to palliative cancer patients shows positive effects on pain and infections—Results from a matched case-control study
www.plosone.org
www.plosone.org
endstream
endobj
3 0 obj
<>/XObject<>>>/CropBox[0 0 612 792]/MediaBox[0 0 612 792]/Parent 12 0 R/Annots 13 0 R/Contents 14 0 R/TrimBox[0 0 612 792]>>
endobj
13 0 obj
[15 0 R 16 0 R 17 0 R 18 0 R 19 0 R 20 0 R 21 0 R 22 0 R 23 0 R 24 0 R 25 0 R 26 0 R 27 0 R 28 0 R 29 0 R 30 0 R 31 0 R 32 0 R 33 0 R 34 0 R]
endobj
15 0 obj
<>/Border[0 0 0]/Dest(Rpone.0184208.ref001)>>
endobj
16 0 obj
<>/Border[0 0 0]/Dest(Rpone.0184208.ref002)>>
endobj
17 0 obj
<>/Border[0 0 0]/Dest(Rpone.0184208.ref003)>>
endobj
18 0 obj
<>/Border[0 0 0]/Dest(Rpone.0184208.ref004)>>
endobj
19 0 obj
<>/Border[0 0 0]/Dest(Rpone.0184208.ref005)>>
endobj
20 0 obj
<>/Border[0 0 0]/Dest(Rpone.0184208.ref006)>>
endobj
21 0 obj
<>/Border[0 0 0]/Dest(Rpone.0184208.ref007)>>
endobj
22 0 obj
<>/Border[0 0 0]/Dest(Rpone.0184208.ref008)>>
endobj
23 0 obj
<>/Border[0 0 0]/Dest(Rpone.0184208.ref010)>>
endobj
24 0 obj
<>/Border[0 0 0]/Dest(Rpone.0184208.ref008)>>
endobj
25 0 obj
<>/Border[0 0 0]/Dest(Rpone.0184208.ref011)>>
endobj
26 0 obj
<>/Border[0 0 0]/Dest(Rpone.0184208.ref016)>>
endobj
27 0 obj
<>/Border[0 0 0]/Dest(Rpone.0184208.ref014)>>
endobj
28 0 obj
<>/Border[0 0 0]/Dest(Rpone.0184208.ref017)>>
endobj
29 0 obj
<>/Border[0 0 0]/Dest(Rpone.0184208.ref018)>>
endobj
30 0 obj
<>/Border[0 0 0]/Dest(Rpone.0184208.ref019)>>
endobj
31 0 obj
<>/Border[0 0 0]/Dest(Rpone.0184208.ref020)>>
endobj
32 0 obj
<>/Border[0 0 0]/Dest(Rpone.0184208.ref021)>>
endobj
33 0 obj
<>/Border[0 0 0]/Dest(Rpone.0184208.ref008)>>
endobj
34 0 obj
<>/Border[0 0 0]/A 35 0 R>>
endobj
35 0 obj
<>
endobj
14 0 obj
[36 0 R 37 0 R 38 0 R 39 0 R 40 0 R 41 0 R 42 0 R 43 0 R 44 0 R 45 0 R 46 0 R 47 0 R 48 0 R 49 0 R 50 0 R 51 0 R 52 0 R 53 0 R 54 0 R]
endobj
36 0 obj
<>stream
q
0.45 0.36 0.35 0.01 k
0 w
575.9997 619.9101 m
199.9998 619.9101 l
199.9998 620.4101 l
575.9997 620.4101 l
f*
0.83 0.64 0.02 0 k
562.5638 432.9071 m
567.326 432.9071 l
h
f*
309.9969 393.9024 m
314.7591 393.9024 l
h
f*
460.6866 367.937 m
465.3921 367.937 l
h
f*
324.7937 354.8976 m
329.5559 354.8976 l
h
f*
454.2803 341.915 m
459.0425 341.915 l
h
f*
220.989 315.9496 m
225.7512 315.9496 l
h
f*
228.0189 315.9496 m
232.7811 315.9496 l
h
f*
269.5181 289.9276 m
274.2803 289.9276 l
h
f*
279.4394 289.9276 m
288.9638 289.9276 l
h
f*
496.8567 276.9449 m
501.6189 276.9449 l
h
f*
503.8866 276.9449 m
513.411 276.9449 l
h
f*
518.5701 276.9449 m
528.0945 276.9449 l
h
f*
203.4142 237.9402 m
212.9386 237.9402 l
h
f*
215.1496 237.9402 m
224.674 237.9402 l
h
f*
226.9417 237.9402 m
236.4661 237.9402 l
h
f*
428.8252 211.9181 m
438.3496 211.9181 l
h
f*
203.4142 185.8961 m
212.9386 185.8961 l
h
f*
215.1496 185.8961 m
224.674 185.8961 l
h
f*
228.0189 146.948 m
232.7811 146.948 l
h
f*
0 g
1 j
1 J
11.4998 0 0 11.4998 200.0125 706.3937 cm
BT
/F2 1 Tf
1 TL
-0.0035 Tc
0 0 Td
(Conclusion)Tj
ET
Q
q
1 j
1 J
0 w
9.5 0 0 9.5 200.0125 689.3858 cm
BT
/F0 1 Tf
1 TL
-0.0042 Tc
0 0 Td
(Vitamin)Tj
3.5149 0 Td
(D)Tj
0.9369 0 Td
(supplementation)Tj
7.4715 0 Td
(to)Tj
1.0444 0 Td
(palliative)Tj
4.052 0 Td
(cancer)Tj
3.1867 0 Td
(patients)Tj
3.6821 0 Td
(is)Tj
0.9309 0 Td
(safe)Tj
2.0887 0 Td
(and)Tj
1.8679 0 Td
(improvement)Tj
5.9438 0 Td
(in)Tj
0.9846 0 Td
(pain)Tj
-35.7044 -1.474 Td
(management)Tj
5.9974 0 Td
(is)Tj
0.931 0 Td
(noted)Tj
2.6914 0 Td
(as)Tj
1.2652 0 Td
(early)Tj
2.3631 0 Td
(as)Tj
1.2652 0 Td
(1)Tj
0.7638 0 Td
(month)Tj
2.9779 0 Td
(after)Tj
2.2021 0 Td
(treatment.)Tj
4.6846 0 Td
(Decreased)Tj
5.0009 0 Td
(infections)Tj
4.3922 0 Td
(are)Tj
1.647 0 Td
(noted)Tj
2.6915 0 Td
(3)Tj
-38.8733 -1.468 Td
(months)Tj
3.4672 0 Td
(after)Tj
2.202 0 Td
(vitamin)Tj
3.3538 0 Td
(D)Tj
0.937 0 Td
(treatment.)Tj
4.6846 0 Td
(The)Tj
1.9275 0 Td
(results)Tj
3.133 0 Td
(from)Tj
2.2081 0 Td
(this)Tj
1.7545 0 Td
(pilot-study)Tj
4.7204 0 Td
(have)Tj
2.3632 0 Td
(been)Tj
2.4169 0 Td
(used)Tj
2.3632 0 Td
(for)Tj
1.3785 0 Td
(the)Tj
-36.9099 -1.474 Td
(power-calculation)Tj
7.9011 0 Td
(of)Tj
1.0444 0 Td
(a)Tj
0.7698 0 Td
(future)Tj
2.7511 0 Td
(randomized,)Tj
5.6573 0 Td
(placebo-con)Tj
5.3828 0 Td
(trolled,)Tj
3.1808 0 Td
(double-blind)Tj
5.5798 0 Td
(study)Tj
2.5899 0 Td
(called)Tj
-34.857 -1.474 Td
(Palliative-D)Tj
5.8662 0 Td
(that)Tj
1.8738 0 Td
(will)Tj
1.5814 0 Td
(start)Tj
2.1484 0 Td
(in)Tj
0.9846 0 Td
(Nov)Tj
1.9813 0 Td
(2017)Tj
2.4109 0 Td
(and)Tj
1.8679 0 Td
(will)Tj
1.5814 0 Td
(include)Tj
3.3419 0 Td
(254)Tj
1.8619 0 Td
(palliative)Tj
4.0521 0 Td
(cancer)Tj
3.1867 0 Td
(patients.)Tj
ET
Q
q
1 j
1 J
0 w
11.9999 0 0 11.9999 200.0125 555.0236 cm
BT
/F2 1 Tf
1 TL
-0.0033 Tc
0 0 Td
(Introduction)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 200.0125 538.0157 cm
BT
/F6 1 Tf
1 TL
-0.004 Tc
0 0 Td
(Palliative)Tj
3.8494 0 Td
(cancer)Tj
2.8459 0 Td
(patients)Tj
3.3676 0 Td
(often)Tj
2.2847 0 Td
(suffer)Tj
2.4775 0 Td
(from)Tj
2.2053 0 Td
(pain)Tj
1.9899 0 Td
(and)Tj
1.7291 0 Td
(infections,)Tj
4.3767 0 Td
(which)Tj
2.6532 0 Td
(may)Tj
1.9275 0 Td
(reduce)Tj
2.914 0 Td
(their)Tj
2.109 0 Td
(quality)Tj
-34.7298 -1.3039 Td
(of)Tj
1.0147 0 Td
(life)Tj
1.4457 0 Td
(and)Tj
1.7291 0 Td
(shorten)Tj
3.2542 0 Td
(their)Tj
2.1089 0 Td
(remaining)Tj
4.3654 0 Td
(life)Tj
1.4456 0 Td
(span.)Tj
2.3074 0 Td
(In)Tj
1.1055 0 Td
(palliative)Tj
3.8098 0 Td
(medicine,)Tj
4.1442 0 Td
(good)Tj
2.228 0 Td
(symptom)Tj
3.9968 0 Td
(manage-)Tj
-32.9553 -1.2982 Td
(ment)Tj
2.3073 0 Td
(and)Tj
1.7292 0 Td
(prevention)Tj
4.5807 0 Td
(of)Tj
1.0148 0 Td
(new)Tj
1.8765 0 Td
(symptoms)Tj
4.3597 0 Td
(are)Tj
1.4513 0 Td
(major)Tj
2.6079 0 Td
(priorities,)Tj
4.0932 0 Td
(aiming)Tj
3.0217 0 Td
(to)Tj
1.0261 0 Td
(maintain)Tj
3.8381 0 Td
(or)Tj
1.0999 0 Td
(even)Tj
-33.0064 -1.2983 Td
(improve)Tj
3.5773 0 Td
(the)Tj
1.474 0 Td
(patient's)Tj
3.5829 0 Td
(quality)Tj
2.9537 0 Td
(of)Tj
1.0148 0 Td
(life.)Tj
1.6668 0 Td
(Since)Tj
2.3584 0 Td
(pharmacological)Tj
6.8484 0 Td
(treatment)Tj
4.1329 0 Td
(often)Tj
2.2847 0 Td
(has)Tj
1.5421 0 Td
(unwanted)Tj
4.2122 0 Td
(side)Tj
-35.6482 -1.3039 Td
(effects,)Tj
2.948 0 Td
(the)Tj
1.474 0 Td
(palliative)Tj
3.804 0 Td
(caregiver)Tj
3.8551 0 Td
(faces)Tj
2.1487 0 Td
(the)Tj
1.474 0 Td
(challenge)Tj
3.9571 0 Td
(of)Tj
1.0148 0 Td
(treating)Tj
3.3279 0 Td
(disease)Tj
3.016 0 Td
(related)Tj
2.9424 0 Td
(symptoms)Tj
4.3596 0 Td
(without)Tj
-34.3216 -1.2983 Td
(causing)Tj
3.2484 0 Td
(harm.)Tj
-2.0522 -1.2982 Td
(Vitamin)Tj
3.5546 0 Td
(D)Tj
0.9524 0 Td
(is)Tj
0.8504 0 Td
(synthesized)Tj
4.8245 0 Td
(in)Tj
1.0375 0 Td
(the)Tj
1.4684 0 Td
(skin)Tj
1.8935 0 Td
(using)Tj
2.3867 0 Td
(energy)Tj
2.9084 0 Td
(from)Tj
2.2053 0 Td
(UVB-light.)Tj
4.6148 0 Td
(Vitamin)Tj
3.5489 0 Td
(D)Tj
0.9525 0 Td
(is)Tj
0.8504 0 Td
(further)Tj
-33.2445 -1.2983 Td
(hydroxylated)Tj
5.4594 0 Td
(in)Tj
1.0318 0 Td
(two)Tj
1.7122 0 Td
(steps)Tj
2.177 0 Td
(into)Tj
1.8425 0 Td
(the)Tj
1.4683 0 Td
(active)Tj
2.5228 0 Td
(form)Tj
2.2054 0 Td
(1,25-dihydroxyvitamin)Tj
9.4166 0 Td
(D,)Tj
1.1792 0 Td
(which)Tj
2.6532 0 Td
(binds)Tj
2.4321 0 Td
(to)Tj
1.0262 0 Td
(the)Tj
-35.1267 -1.3039 Td
(vitamin)Tj
3.3108 0 Td
(D)Tj
0.9524 0 Td
(receptor)Tj
3.5547 0 Td
(\(VDR\).)Tj
3.1804 0 Td
(The)Tj
1.7802 0 Td
(activated)Tj
3.7813 0 Td
(VDR)Tj
2.2734 0 Td
(complex)Tj
3.6227 0 Td
(regulates)Tj
3.77 0 Td
(a)Tj
0.6577 0 Td
(large)Tj
2.1599 0 Td
(number)Tj
3.4129 0 Td
(of)Tj
1.0148 0 Td
(genes)Tj
2.4435 0 Td
([)Tj
0.83 0.64 0.02 0 k
(1)Tj
0 g
(])Tj
-35.9147 -1.2983 Td
(and)Tj
1.7291 0 Td
(vitamin)Tj
3.3108 0 Td
(D)Tj
0.9525 0 Td
(is)Tj
0.8503 0 Td
(important)Tj
4.2803 0 Td
(for)Tj
1.389 0 Td
(a)Tj
0.652 0 Td
(healthy)Tj
3.1351 0 Td
(immune)Tj
3.6226 0 Td
(system)Tj
2.9424 0 Td
(since)Tj
2.2393 0 Td
(it)Tj
0.788 0 Td
(induces)Tj
3.2995 0 Td
(the)Tj
1.4684 0 Td
(synthesis)Tj
3.8211 0 Td
(of)Tj
1.0148 0 Td
(anti-)Tj
-35.4952 -1.2983 Td
(microbial)Tj
4.0591 0 Td
(peptides)Tj
3.5603 0 Td
(in)Tj
1.0318 0 Td
(immune)Tj
3.6284 0 Td
(cells)Tj
1.9218 0 Td
(and)Tj
1.7292 0 Td
(on)Tj
1.2755 0 Td
(mucosal)Tj
3.5377 0 Td
(surfaces)Tj
3.4128 0 Td
(as)Tj
1.0148 0 Td
(a)Tj
0.652 0 Td
(part)Tj
1.8425 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
1.4684 0 Td
(first)Tj
2.1996 0 Td
(line)Tj
1.7008 0 Td
(defense)Tj
-34.0495 -1.3039 Td
(against)Tj
3.0273 0 Td
(invading)Tj
3.7304 0 Td
(microbes)Tj
3.9005 0 Td
([)Tj
0.83 0.64 0.02 0 k
(2)Tj
0 g
(].)Tj
-9.462 -1.2982 Td
(The)Tj
1.7858 0 Td
(pro-form)Tj
3.9514 0 Td
(25-hydroxyvitamin)Tj
7.92 0 Td
(D)Tj
0.9581 0 Td
(\(25-OHD\))Tj
4.4504 0 Td
(is)Tj
0.8504 0 Td
(more)Tj
2.3414 0 Td
(stable)Tj
2.4888 0 Td
(than)Tj
2.0296 0 Td
(the)Tj
1.4683 0 Td
(active)Tj
2.5171 0 Td
(1,25)Tj
1.8766 0 Td
(hydroxy-)Tj
-33.8341 -1.2983 Td
(vitamin)Tj
3.3108 0 Td
(D,)Tj
1.1792 0 Td
(with)Tj
1.9956 0 Td
(a)Tj
0.6576 0 Td
(half-life)Tj
3.2882 0 Td
(of)Tj
1.0148 0 Td
(about)Tj
2.4944 0 Td
(3)Tj
0.6974 0 Td
(weeks)Tj
2.6078 0 Td
(compared)Tj
4.2406 0 Td
(to)Tj
1.0262 0 Td
(4)Tj
0.6973 0 Td
(hours)Tj
2.5171 0 Td
([)Tj
0.83 0.64 0.02 0 k
(3)Tj
0 g
(])Tj
1.372 0 Td
(which)Tj
2.6532 0 Td
(is)Tj
0.8447 0 Td
(why)Tj
1.8879 0 Td
(it)Tj
0.788 0 Td
(is)Tj
0.8447 0 Td
(used)Tj
2.0636 0 Td
(for)Tj
-36.1811 -1.3039 Td
(evaluation)Tj
4.3596 0 Td
(of)Tj
1.0148 0 Td
(vitamin)Tj
3.3108 0 Td
(D)Tj
0.9525 0 Td
(status)Tj
2.5001 0 Td
([)Tj
0.83 0.64 0.02 0 k
(4)Tj
0 g
(].)Tj
1.6044 0 Td
(Serum)Tj
2.8347 0 Td
(levels)Tj
2.3754 0 Td
(of)Tj
1.0148 0 Td
(25-OHD)Tj
3.7757 0 Td
(below)Tj
2.5852 0 Td
(50)Tj
1.1735 0 Td
(nmol/L)Tj
3.2088 0 Td
(are)Tj
1.4513 0 Td
(considered)Tj
4.5978 0 Td
(to)Tj
-36.7594 -1.2983 Td
(be)Tj
1.1508 0 Td
(insufficient)Tj
4.7282 0 Td
(according)Tj
4.1839 0 Td
(to)Tj
1.0261 0 Td
(the)Tj
1.4684 0 Td
(Institute)Tj
3.5886 0 Td
(of)Tj
1.0148 0 Td
(Medicine)Tj
3.9911 0 Td
(in)Tj
1.0375 0 Td
(the)Tj
1.4684 0 Td
(US)Tj
1.4286 0 Td
([)Tj
0.83 0.64 0.02 0 k
(5)Tj
0 g
(].)Tj
1.6044 0 Td
(Furthermore,)Tj
5.6126 0 Td
(there)Tj
2.2677 0 Td
(is)Tj
-34.5711 -1.2982 Td
(increasing)Tj
4.3313 0 Td
(evidence)Tj
3.7077 0 Td
(that)Tj
1.7801 0 Td
(levels)Tj
2.3754 0 Td
(of)Tj
1.0148 0 Td
(25-OHD)Tj
3.7701 0 Td
(above)Tj
2.5455 0 Td
(75)Tj
1.1735 0 Td
(nmol/L)Tj
3.2088 0 Td
(are)Tj
1.4513 0 Td
(optimal)Tj
3.3052 0 Td
(for)Tj
1.389 0 Td
(the)Tj
1.4683 0 Td
(immune)Tj
3.6283 0 Td
(sys-)Tj
-35.1493 -1.2983 Td
(tem)Tj
1.7574 0 Td
([)Tj
0.83 0.64 0.02 0 k
(6)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
(7)Tj
0 g
(].)Tj
-0.5612 -1.3039 Td
(Low)Tj
1.9502 0 Td
(serum)Tj
2.7269 0 Td
(levels)Tj
2.3754 0 Td
(of)Tj
1.0148 0 Td
(vitamin)Tj
3.3052 0 Td
(D)Tj
0.9581 0 Td
(are)Tj
1.4513 0 Td
(more)Tj
2.3414 0 Td
(common)Tj
3.8438 0 Td
(in)Tj
1.0375 0 Td
(palliative)Tj
3.804 0 Td
(cancer)Tj
2.846 0 Td
(patients)Tj
3.3675 0 Td
(than)Tj
2.0296 0 Td
(in)Tj
-34.2479 -1.2983 Td
(healthy)Tj
3.1294 0 Td
(controls)Tj
3.4809 0 Td
([)Tj
0.83 0.64 0.02 0 k
(8)Tj
0 g
()Tj
0.83 0.64 0.02 0 k
(10)Tj
0 g
(].)Tj
3.0671 0 Td
(Both)Tj
2.1316 0 Td
(observational)Tj
5.5786 0 Td
(and)Tj
1.7291 0 Td
(interventional)Tj
5.8507 0 Td
(studies)Tj
2.9876 0 Td
(suggest)Tj
3.1181 0 Td
(a)Tj
0.652 0 Td
(role)Tj
1.7688 0 Td
(of)Tj
1.0091 0 Td
(vitamin)Tj
-34.503 -1.2983 Td
(D)Tj
0.9467 0 Td
(in)Tj
1.0318 0 Td
(pain)Tj
1.9786 0 Td
(intensity)Tj
3.6793 0 Td
(and)Tj
1.7235 0 Td
(in)Tj
1.0261 0 Td
(management)Tj
5.4312 0 Td
(of)Tj
1.0091 0 Td
(pain)Tj
1.9786 0 Td
(in)Tj
1.0261 0 Td
(varying)Tj
3.2088 0 Td
(clinical)Tj
3.0727 0 Td
(settings)Tj
3.2315 0 Td
([)Tj
0.83 0.64 0.02 0 k
(8)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
(11)Tj
0 g
()Tj
0.83 0.64 0.02 0 k
(16)Tj
0 g
(].)Tj
4.2406 0 Td
(Neverthe-)Tj
-33.5846 -1.3039 Td
(less,)Tj
1.8368 0 Td
(3)Tj
0.6973 0 Td
(meta-analyses)Tj
5.8053 0 Td
(reviewing)Tj
4.1272 0 Td
(previously)Tj
4.3484 0 Td
(performed)Tj
4.473 0 Td
(randomized,)Tj
5.2838 0 Td
(controlled)Tj
4.3199 0 Td
(trials)Tj
2.194 0 Td
(\(RCTs\))Tj
-33.0857 -1.2982 Td
(could)Tj
2.4491 0 Td
(not)Tj
1.576 0 Td
(establish)Tj
3.6454 0 Td
(a)Tj
0.6519 0 Td
(correlation)Tj
4.6205 0 Td
(between)Tj
3.5262 0 Td
(vitamin)Tj
3.3109 0 Td
(D)Tj
0.9581 0 Td
(supplementation)Tj
6.9562 0 Td
(and)Tj
1.7291 0 Td
(pain)Tj
1.9899 0 Td
(reduction)Tj
-31.4133 -1.2983 Td
([)Tj
0.83 0.64 0.02 0 k
(14)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
(17)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
(18)Tj
0 g
(].)Tj
4.4276 0 Td
(In)Tj
1.1112 0 Td
(contrast,)Tj
3.685 0 Td
(a)Tj
0.6577 0 Td
(recent)Tj
2.7042 0 Td
(review)Tj
2.846 0 Td
(of)Tj
1.0148 0 Td
(published)Tj
4.1272 0 Td
(RCTs)Tj
2.4774 0 Td
(concluded)Tj
4.371 0 Td
(that)Tj
1.7802 0 Td
(a)Tj
0.652 0 Td
(significantly)Tj
-29.8543 -1.3039 Td
(greater)Tj
3.0047 0 Td
(mean)Tj
2.4491 0 Td
(decrease)Tj
3.6056 0 Td
(in)Tj
1.0375 0 Td
(pain)Tj
1.9842 0 Td
(score)Tj
2.3074 0 Td
(could)Tj
2.4491 0 Td
(be)Tj
1.1509 0 Td
(observed)Tj
3.7984 0 Td
(with)Tj
1.9956 0 Td
(vitamin)Tj
3.3108 0 Td
(D)Tj
0.9581 0 Td
(supplementation)Tj
6.9562 0 Td
(com-)Tj
-35.0076 -1.2983 Td
(pared)Tj
2.4831 0 Td
(to)Tj
1.0204 0 Td
(placebo)Tj
3.2712 0 Td
(treatment)Tj
4.1272 0 Td
(in)Tj
1.0262 0 Td
(patients)Tj
3.3618 0 Td
(with)Tj
1.9899 0 Td
(chronic)Tj
3.2825 0 Td
(pain)Tj
1.9786 0 Td
([)Tj
0.83 0.64 0.02 0 k
(19)Tj
0 g
(].)Tj
2.0693 0 Td
(There)Tj
2.5682 0 Td
(is)Tj
0.839 0 Td
(also)Tj
1.7631 0 Td
(increasing)Tj
4.32 0 Td
(evidence)Tj
-34.1005 -1.2983 Td
(that)Tj
1.7744 0 Td
(vitamin)Tj
3.3109 0 Td
(D)Tj
0.9581 0 Td
(supplementation)Tj
6.9562 0 Td
(may)Tj
1.9275 0 Td
(reduce)Tj
2.9197 0 Td
(depressive)Tj
4.3483 0 Td
(symptoms)Tj
4.3596 0 Td
(and)Tj
1.7292 0 Td
(improve)Tj
3.5829 0 Td
(quality)Tj
2.9537 0 Td
(of)Tj
1.0148 0 Td
(life)Tj
-35.8353 -1.3039 Td
([)Tj
0.83 0.64 0.02 0 k
(20)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
(21)Tj
0 g
(].)Tj
1.1962 -1.2982 Td
(A)Tj
0.907 0 Td
(previous)Tj
3.651 0 Td
(prospective,)Tj
5.006 0 Td
(observational)Tj
5.5842 0 Td
(study)Tj
2.3868 0 Td
(performed)Tj
4.4673 0 Td
(at)Tj
0.9525 0 Td
(our)Tj
1.6271 0 Td
(palliative)Tj
3.8097 0 Td
(care)Tj
1.8708 0 Td
(unit)Tj
1.8652 0 Td
(in)Tj
1.0318 0 Td
(Stock-)Tj
-34.3556 -1.2983 Td
(holm,)Tj
2.5454 0 Td
(studied)Tj
3.1522 0 Td
(the)Tj
1.4683 0 Td
(relationship)Tj
4.9889 0 Td
(between)Tj
3.532 0 Td
(25-OHD)Tj
3.77 0 Td
(levels)Tj
2.3755 0 Td
(and)Tj
1.7291 0 Td
(opioid)Tj
2.8119 0 Td
(dose,)Tj
2.2677 0 Td
(infections)Tj
4.1499 0 Td
(and)Tj
1.7291 0 Td
(quality)Tj
-34.52 -1.2983 Td
(of)Tj
1.0147 0 Td
(life)Tj
1.4457 0 Td
([)Tj
0.83 0.64 0.02 0 k
(8)Tj
0 g
(].)Tj
1.5987 0 Td
(In)Tj
1.1112 0 Td
(this)Tj
1.6724 0 Td
(study,)Tj
2.6136 0 Td
(lower)Tj
2.4548 0 Td
(serum)Tj
2.7212 0 Td
(levels)Tj
2.3754 0 Td
(of)Tj
1.0148 0 Td
(25-OHD)Tj
3.7701 0 Td
(correlated)Tj
4.2462 0 Td
(with)Tj
2.0013 0 Td
(a)Tj
0.652 0 Td
(higher)Tj
2.8006 0 Td
(fentanyl)Tj
3.4639 0 Td
(dose.)Tj
-34.9566 -1.3039 Td
(However,)Tj
4.0761 0 Td
(there)Tj
2.2621 0 Td
(was)Tj
1.7008 0 Td
(no)Tj
1.2755 0 Td
(correlation)Tj
4.6205 0 Td
(between)Tj
3.5263 0 Td
(serum)Tj
2.7212 0 Td
(25-OHD)Tj
3.7757 0 Td
(levels)Tj
2.3754 0 Td
(and)Tj
1.7292 0 Td
(infections)Tj
4.1499 0 Td
(or)Tj
1.0998 0 Td
(quality)Tj
2.9537 0 Td
(of)Tj
-36.2662 -1.2982 Td
(life.)Tj
1.6667 0 Td
(No)Tj
1.4627 0 Td
(vitamin)Tj
3.3108 0 Td
(D-supplementation)Tj
8.0447 0 Td
(was)Tj
1.7008 0 Td
(given)Tj
2.3811 0 Td
(in)Tj
1.0318 0 Td
(that)Tj
1.7801 0 Td
(study.)Tj
2.6135 0 Td
(After)Tj
2.2847 0 Td
(this)Tj
1.6781 0 Td
(study)Tj
2.3868 0 Td
(we)Tj
1.3266 0 Td
(have)Tj
2.0636 0 Td
(changed)Tj
-33.732 -1.2983 Td
(the)Tj
1.4683 0 Td
(guidelines)Tj
4.2803 0 Td
(at)Tj
0.9524 0 Td
(our)Tj
1.6214 0 Td
(ward)Tj
2.2394 0 Td
(and)Tj
1.7291 0 Td
(patients)Tj
3.3675 0 Td
(with)Tj
2.0013 0 Td
(25-hydroxyvitamn)Tj
7.6478 0 Td
(D)Tj
0.9581 0 Td
(levels)Tj
2.3754 0 Td
(of)Tj
/F10 1 Tf
0 Tc
1.0148 0 Td
(<)Tj
/F6 1 Tf
-0.004 Tc
0.9921 0 Td
(75)Tj
1.1736 0 Td
(nmol/L)Tj
3.2088 0 Td
(are)Tj
-35.0303 -1.3039 Td
(now)Tj
1.9558 0 Td
(offered)Tj
3.0501 0 Td
(vitamin)Tj
3.3108 0 Td
(D)Tj
0.9582 0 Td
(supplementation.)Tj
7.1829 0 Td
(In)Tj
1.1055 0 Td
(the)Tj
1.474 0 Td
(current)Tj
3.1805 0 Td
(study)Tj
2.3924 0 Td
(we)Tj
1.3266 0 Td
(wanted)Tj
3.1351 0 Td
(to)Tj
1.0261 0 Td
(determine)Tj
4.3257 0 Td
(if)Tj
0.771 0 Td
(the)Tj
-35.1947 -1.2983 Td
(vitamin)Tj
3.3108 0 Td
(D)Tj
0.9524 0 Td
(supplementation)Tj
6.9619 0 Td
(could)Tj
2.4491 0 Td
(improve)Tj
3.583 0 Td
(pain)Tj
1.9842 0 Td
(management,)Tj
5.6636 0 Td
(reduce)Tj
2.914 0 Td
(infections)Tj
4.1556 0 Td
(and)Tj
1.7291 0 Td
(improve)Tj
ET
Q
q
1 j
1 J
0 w
576 737.1 m
36 737.1 l
36 737.6 l
576 737.6 l
f*
36 741.2598 107.1496 23.6976 re
W* n
q
107.0929 0 0 23.6409 36 741.3165 cm
q
/I0 Do
Q
Q
Q
q
0 0 612 792 re
W* n
1 j
1 J
0 w
7.9999 0 0 7.9999 447.6472 745.7952 cm
BT
/F0 1 Tf
1 TL
-0.005 Tc
0 0 Td
(Vitamin)Tj
3.5008 0 Td
(D)Tj
0.9283 0 Td
(in)Tj
0.978 0 Td
(palliative)Tj
4.0252 0 Td
(cancer)Tj
3.1677 0 Td
(patients)Tj
ET
Q
q
1 j
1 J
0 w
36 48.0002 m
576 48.0002 l
576 47.5002 l
36 47.5002 l
f*
0.83 0.64 0.02 0 k
81.5811 34.9228 m
237.8835 34.9228 l
h
f*
0 g
7.9999 0 0 7.9999 36 36 cm
BT
/F0 1 Tf
1 TL
-0.005 Tc
0 0 Td
(PLOS)Tj
2.8559 0 Td
(ONE)Tj
2.3669 0 Td
(|)Tj
0.83 0.64 0.02 0 k
0.4748 0 Td
(https://doi.or)Tj
5.4142 0 Td
(g/10.137)Tj
3.8198 0 Td
(1/journal.po)Tj
5.1236 0 Td
(ne.01842)Tj
4.089 0 Td
(08)Tj
0 g
2.0906 0 Td
(August)Tj
3.2882 0 Td
(31,)Tj
1.5874 0 Td
(2017)Tj
34.0302 0 Td
(2)Tj
0.7654 0 Td
(/)Tj
0.496 0 Td
(14)Tj
/F8 1 Tf
-0.025 Tc
-66.402 84.0904 Td
(Stockholm)Tj
4.2094 0 Td
(County)Tj
2.8418 0 Td
(Council,)Tj
3.1961 0 Td
(The)Tj
1.5945 0 Td
(Swedish)Tj
3.3661 0 Td
(Cancer)Tj
-15.2079 -1.3748 Td
(Society)Tj
2.9338 0 Td
(and)Tj
1.5874 0 Td
(Karolinska)Tj
4.0678 0 Td
(Institutet.)Tj
/F7 1 Tf
-8.589 -2.126 Td
(Competing)Tj
4.3795 0 Td
(interests)Tj
3.3307 0 Td
(:)Tj
/F8 1 Tf
0.4819 0 Td
(The)Tj
1.5875 0 Td
(authors)Tj
3.0401 0 Td
(have)Tj
1.963 0 Td
(declared)Tj
-14.7827 -1.3749 Td
(that)Tj
1.6228 0 Td
(no)Tj
1.1693 0 Td
(competing)Tj
4.1599 0 Td
(interests)Tj
ET
endstream
endobj
37 0 obj
<>stream
endstream
endobj
38 0 obj
<>stream
endstream
endobj
39 0 obj
<>stream
endstream
endobj
40 0 obj
<>stream
endstream
endobj
41 0 obj
<>stream
endstream
endobj
42 0 obj
<>stream
endstream
endobj
43 0 obj
<>stream
endstream
endobj
44 0 obj
<>stream
endstream
endobj
45 0 obj
<>stream
endstream
endobj
46 0 obj
<>stream
endstream
endobj
47 0 obj
<>stream
endstream
endobj
48 0 obj
<>stream
endstream
endobj
49 0 obj
<>stream
endstream
endobj
50 0 obj
<>stream
endstream
endobj
51 0 obj
<>stream
endstream
endobj
52 0 obj
<>stream
endstream
endobj
53 0 obj
<>stream
endstream
endobj
54 0 obj
<>stream
BT
10.3394 79.2147 Td
(exist.)Tj
ET
Q
endstream
endobj
55 0 obj
<>/XObject<>>>/CropBox[0 0 612 792]/MediaBox[0 0 612 792]/Parent 12 0 R/Annots 57 0 R/Contents 58 0 R/TrimBox[0 0 612 792]>>
endobj
57 0 obj
[59 0 R 60 0 R]
endobj
59 0 obj
<>/Border[0 0 0]/Dest(Rpone.0184208.ref008)>>
endobj
60 0 obj
<>/Border[0 0 0]/A 61 0 R>>
endobj
61 0 obj
<>
endobj
58 0 obj
[62 0 R 63 0 R 64 0 R 65 0 R 66 0 R 67 0 R]
endobj
62 0 obj
<>stream
q
0.83 0.64 0.02 0 k
482.2866 375.0803 m
487.0488 375.0803 l
h
f*
0 g
1 j
1 J
0 w
10 0 0 10 200.0125 707.4141 cm
BT
/F6 1 Tf
1 TL
-0.004 Tc
0 0 Td
(quality)Tj
2.9536 0 Td
(of)Tj
1.0148 0 Td
(life)Tj
1.4457 0 Td
(in)Tj
1.0375 0 Td
(our)Tj
1.6214 0 Td
(palliative)Tj
3.8097 0 Td
(cancer)Tj
2.846 0 Td
(patients.)Tj
3.5943 0 Td
(Finally,)Tj
3.1691 0 Td
(we)Tj
1.3266 0 Td
(also)Tj
1.7688 0 Td
(wanted)Tj
3.1351 0 Td
(to)Tj
1.0261 0 Td
(evaluate)Tj
3.464 0 Td
(if)Tj
0.771 0 Td
(there)Tj
2.2677 0 Td
(were)Tj
-35.2514 -1.3039 Td
(any)Tj
1.6554 0 Td
(negative)Tj
3.5376 0 Td
(side)Tj
1.7971 0 Td
(effects)Tj
2.727 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
1.4683 0 Td
(treatment)Tj
4.1385 0 Td
(in)Tj
1.0318 0 Td
(this)Tj
1.6725 0 Td
(patient)Tj
3.0104 0 Td
(group.)Tj
ET
Q
q
1 j
1 J
0 w
11.9999 0 0 11.9999 200.0125 665.2913 cm
BT
/F2 1 Tf
1 TL
-0.0033 Tc
0 0 Td
(Methods)Tj
/F0 1 Tf
0 -1.5023 Td
(Study)Tj
2.7543 0 Td
(cohort)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 200.0125 630.2551 cm
BT
/F6 1 Tf
1 TL
-0.004 Tc
0 0 Td
(This)Tj
1.9842 0 Td
(is)Tj
0.8504 0 Td
(a)Tj
0.6519 0 Td
(case-control)Tj
5.1137 0 Td
(study)Tj
2.3924 0 Td
(where)Tj
2.6476 0 Td
(the)Tj
1.4683 0 Td
(vitamin)Tj
3.3109 0 Td
(D)Tj
0.9581 0 Td
(supplemented)Tj
5.8563 0 Td
(patients)Tj
3.3675 0 Td
(were)Tj
2.1203 0 Td
(followed)Tj
3.651 0 Td
(pro-)Tj
-34.3726 -1.2982 Td
(spectively)Tj
4.0875 0 Td
(with)Tj
2.0012 0 Td
(regards)Tj
3.1691 0 Td
(to)Tj
1.0262 0 Td
(their)Tj
2.1089 0 Td
(opioid)Tj
2.812 0 Td
(consumption,)Tj
5.7713 0 Td
(infections)Tj
4.1556 0 Td
(and)Tj
1.7291 0 Td
(quality)Tj
2.9537 0 Td
(of)Tj
1.0148 0 Td
(life.)Tj
1.6724 0 Td
(The)Tj
1.7801 0 Td
(supple-)Tj
-34.2819 -1.2983 Td
(mented)Tj
3.2598 0 Td
(patients)Tj
3.3675 0 Td
(were)Tj
2.126 0 Td
(later)Tj
1.9899 0 Td
(matched)Tj
3.6737 0 Td
(with)Tj
2.0012 0 Td
(untreated)Tj
4.0705 0 Td
(control-patients)Tj
6.6217 0 Td
(from)Tj
2.2054 0 Td
(a)Tj
0.6519 0 Td
(previous)Tj
3.651 0 Td
(study)Tj
2.3925 0 Td
(at)Tj
-36.0111 -1.3039 Td
(the)Tj
1.4683 0 Td
(same)Tj
2.2564 0 Td
(ward,)Tj
2.4661 0 Td
(performed)Tj
4.4674 0 Td
(before)Tj
2.7382 0 Td
(the)Tj
1.474 0 Td
(new)Tj
1.8765 0 Td
(guidelines)Tj
4.2746 0 Td
(regarding)Tj
4.0933 0 Td
(vitamin)Tj
3.3108 0 Td
(D-treatment)Tj
5.2214 0 Td
(were)Tj
-33.647 -1.2983 Td
(introduced.)Tj
4.8642 0 Td
(In)Tj
1.1111 0 Td
(this)Tj
1.6725 0 Td
(study)Tj
2.3924 0 Td
(cohort,)Tj
3.0784 0 Td
(palliative)Tj
3.8097 0 Td
(cancer)Tj
2.846 0 Td
(patients)Tj
3.3676 0 Td
(were)Tj
2.1203 0 Td
(supplemented)Tj
5.8563 0 Td
(with)Tj
1.9956 0 Td
(vitamin)Tj
3.3108 0 Td
(D)Tj
-36.4249 -1.2982 Td
(4000)Tj
2.1203 0 Td
(IE/day)Tj
2.8743 0 Td
(\(Detremin\))Tj
4.7905 0 Td
(and)Tj
1.7291 0 Td
(followed)Tj
3.651 0 Td
(for)Tj
1.3833 0 Td
(up)Tj
1.2699 0 Td
(to)Tj
1.0205 0 Td
(3)Tj
0.6973 0 Td
(months.)Tj
-18.34 -1.3039 Td
(Palliative)Tj
3.8551 0 Td
(cancer)Tj
2.8403 0 Td
(patients)Tj
3.3675 0 Td
(were)Tj
2.126 0 Td
(recruited)Tj
3.8551 0 Td
(consecutively)Tj
5.5785 0 Td
(when)Tj
2.4038 0 Td
(they)Tj
1.9218 0 Td
(were)Tj
2.126 0 Td
(admitted)Tj
3.8154 0 Td
(to)Tj
1.0262 0 Td
(ASIH)Tj
-34.1119 -1.2983 Td
(Stockholm)Tj
4.5183 0 Td
(So)Tj
0 Tc
0.5386 0 Td
()Tj
-0.004 Tc
0.4479 0 Td
(dra,)Tj
1.7745 0 Td
(L)Tj
/F11 1 Tf
[()]TJ
/F6 1 Tf
(ngbro)Tj
3.5943 0 Td
(Park)Tj
2.0806 0 Td
(Advanced)Tj
4.2406 0 Td
(Palliative)Tj
3.8494 0 Td
(Home)Tj
2.7383 0 Td
(Care)Tj
2.1146 0 Td
(Team)Tj
2.5058 0 Td
(or)Tj
1.0999 0 Td
(Hospice)Tj
3.4865 0 Td
(Ward)Tj
2.5172 0 Td
(from)Tj
-35.5065 -1.2983 Td
(Sept)Tj
1.9332 0 Td
(2015)Tj
2.1203 0 Td
(to)Tj
1.0261 0 Td
(June)Tj
2.0523 0 Td
(2016.)Tj
2.347 0 Td
(Inclusion)Tj
3.9912 0 Td
(criteria)Tj
3.0727 0 Td
(were:)Tj
2.3471 0 Td
(age)Tj
1.5477 0 Td
(18)Tj
1.1679 0 Td
(or)Tj
1.0998 0 Td
(above,)Tj
2.7723 0 Td
(incurable)Tj
3.9685 0 Td
(cancer)Tj
2.8403 0 Td
(\(any)Tj
2.0012 0 Td
(type)Tj
1.9105 0 Td
(of)Tj
-36.1981 -1.3039 Td
(cancer\),)Tj
3.4072 0 Td
(expected)Tj
3.7247 0 Td
(survival)Tj
3.3335 0 Td
(time)Tj
2.0296 0 Td
(of)Tj
1.0148 0 Td
(more)Tj
2.3414 0 Td
(than)Tj
2.0296 0 Td
(1)Tj
0.6973 0 Td
(month)Tj
2.9197 0 Td
(and)Tj
1.7291 0 Td
(serum)Tj
2.7269 0 Td
(levels)Tj
2.3754 0 Td
(of)Tj
1.0148 0 Td
(25-OHD)Tj
/F10 1 Tf
0 Tc
3.7701 0 Td
(<)Tj
/F6 1 Tf
-0.004 Tc
0.9921 0 Td
(75)Tj
-34.1062 -1.2983 Td
(nmol/L,)Tj
3.4355 0 Td
(i.e.)Tj
1.3606 0 Td
(insufficient)Tj
5.1194 0 Td
(levels)Tj
2.7666 0 Td
(according)Tj
4.1896 0 Td
(to)Tj
1.0261 0 Td
(local)Tj
2.0749 0 Td
(guidelines)Tj
4.2747 0 Td
(at)Tj
0.9524 0 Td
(Karolinska)Tj
4.5637 0 Td
(University)Tj
4.3994 0 Td
(Hospital)Tj
-34.1629 -1.2982 Td
(Stockholm.)Tj
4.7451 0 Td
(The)Tj
1.7802 0 Td
(patients)Tj
3.3732 0 Td
(were)Tj
2.1203 0 Td
(supplemented)Tj
5.8563 0 Td
(with)Tj
1.9956 0 Td
(vitamin)Tj
3.3108 0 Td
(D3)Tj
1.4287 0 Td
(\(Detremin:)Tj
4.6771 0 Td
(cholecalciferol)Tj
5.9754 0 Td
(\(vita-)Tj
-35.2627 -1.2983 Td
(min)Tj
1.8538 0 Td
(D3\))Tj
1.7745 0 Td
(dissolved)Tj
3.8948 0 Td
(in)Tj
1.0318 0 Td
(Miglyoil\).)Tj
4.1328 0 Td
(Patients)Tj
3.4129 0 Td
(took)Tj
2.0296 0 Td
(8)Tj
0.6917 0 Td
(drops)Tj
2.5058 0 Td
(of)Tj
1.0148 0 Td
(this)Tj
1.6724 0 Td
(Detremin)Tj
4.1102 0 Td
(every)Tj
2.3471 0 Td
(day;)Tj
1.8595 0 Td
(correspond-)Tj
-32.3317 -1.3039 Td
(ing)Tj
1.5023 0 Td
(to)Tj
1.0205 0 Td
(4000)Tj
2.1259 0 Td
(IE)Tj
1.1282 0 Td
(=)Tj
0.7994 0 Td
(100)Tj
/F11 1 Tf
1.6497 0 Td
[()]TJ
/F6 1 Tf
(g.)Tj
1.4174 0 Td
(All)Tj
1.3946 0 Td
(patients)Tj
3.3675 0 Td
(that)Tj
1.7802 0 Td
(survived)Tj
3.6056 0 Td
(for)Tj
1.389 0 Td
(more)Tj
2.3414 0 Td
(than)Tj
2.0239 0 Td
(1)Tj
0.6973 0 Td
(month)Tj
2.9197 0 Td
(were)Tj
2.126 0 Td
(included)Tj
3.7133 0 Td
(in)Tj
1.0318 0 Td
(the)Tj
-36.0337 -1.2983 Td
(final)Tj
2.0012 0 Td
(analysis.)Tj
ET
Q
q
1 j
1 J
0 w
11.9999 0 0 11.9999 200.0125 419.1307 cm
BT
/F0 1 Tf
1 TL
-0.0033 Tc
0 0 Td
(Control)Tj
3.4016 0 Td
(group)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 200.0125 402.1228 cm
BT
/F6 1 Tf
1 TL
-0.004 Tc
0 0 Td
(Each)Tj
2.1656 0 Td
(treated)Tj
2.9934 0 Td
(patient)Tj
2.999 0 Td
(was)Tj
1.6951 0 Td
(matched)Tj
3.668 0 Td
(with)Tj
1.9899 0 Td
(an)Tj
1.1962 0 Td
(untreated)Tj
4.0649 0 Td
(control.)Tj
3.3449 0 Td
(Controls)Tj
3.7133 0 Td
(were)Tj
2.1203 0 Td
(taken)Tj
2.4095 0 Td
(from)Tj
2.1996 0 Td
(a)Tj
0.652 0 Td
(previ-)Tj
-35.2117 -1.2982 Td
(ous)Tj
1.6157 0 Td
(observational)Tj
5.5785 0 Td
(vitamin)Tj
3.3109 0 Td
(D)Tj
0.9524 0 Td
(study)Tj
2.3924 0 Td
(at)Tj
0.9525 0 Td
(our)Tj
1.6271 0 Td
(ward)Tj
2.2336 0 Td
(\(n)Tj
1.1112 0 Td
(=)Tj
0.7994 0 Td
(169\))Tj
1.9842 0 Td
(that)Tj
1.7802 0 Td
(was)Tj
1.7007 0 Td
(started)Tj
2.931 0 Td
(2014.)Tj
2.3471 0 Td
(The)Tj
1.7858 0 Td
(first)Tj
1.8029 0 Td
(100)Tj
-34.9056 -1.2983 Td
(patients)Tj
3.3675 0 Td
(included)Tj
3.7134 0 Td
(in)Tj
1.0318 0 Td
(that)Tj
1.7801 0 Td
(study)Tj
2.3924 0 Td
(are)Tj
1.4457 0 Td
(described)Tj
4.0535 0 Td
(in)Tj
1.0375 0 Td
(a)Tj
0.6519 0 Td
(previous)Tj
3.651 0 Td
(publication)Tj
4.7622 0 Td
([)Tj
0.83 0.64 0.02 0 k
(8)Tj
0 g
(].)Tj
1.5987 0 Td
(In)Tj
1.1112 0 Td
(that)Tj
1.7802 0 Td
(study)Tj
2.3867 0 Td
(the)Tj
-34.7638 -1.3039 Td
(same)Tj
2.2563 0 Td
(parameters)Tj
4.6715 0 Td
(as)Tj
1.0204 0 Td
(in)Tj
1.0319 0 Td
(the)Tj
1.4683 0 Td
(present)Tj
3.1634 0 Td
(study)Tj
2.3925 0 Td
(were)Tj
2.1203 0 Td
(monitored,)Tj
4.7168 0 Td
(and)Tj
1.7291 0 Td
(25-OHD)Tj
3.7757 0 Td
(was)Tj
1.6951 0 Td
(measured,)Tj
4.337 0 Td
(but)Tj
1.5534 0 Td
(no)Tj
-35.9317 -1.2983 Td
(vitamin)Tj
3.3108 0 Td
(D)Tj
0.9524 0 Td
(treatment)Tj
4.1386 0 Td
(was)Tj
1.6951 0 Td
(given.)Tj
2.6079 0 Td
(The)Tj
1.7801 0 Td
(patients)Tj
3.3675 0 Td
(in)Tj
1.0375 0 Td
(the)Tj
1.4683 0 Td
(study)Tj
2.3925 0 Td
(cohort)Tj
2.8516 0 Td
(were)Tj
2.126 0 Td
(matched)Tj
3.6737 0 Td
(with)Tj
1.9955 0 Td
(untreated)Tj
-33.3975 -1.2982 Td
(controls)Tj
3.4809 0 Td
(regarding,)Tj
4.3199 0 Td
(sex,)Tj
1.6952 0 Td
(approximate)Tj
5.2724 0 Td
(age)Tj
1.542 0 Td
(\()Tj
/F11 1 Tf
[()]TJ
/F6 1 Tf
(10)Tj
2.0806 0 Td
(years\),)Tj
2.8346 0 Td
(cancer)Tj
2.8403 0 Td
(type)Tj
1.9162 0 Td
(\(divided)Tj
3.5547 0 Td
(into)Tj
1.8425 0 Td
(the)Tj
1.4683 0 Td
(8)Tj
0.6973 0 Td
(groups:)Tj
-33.5449 -1.3039 Td
(breast)Tj
2.6135 0 Td
(cancer,)Tj
3.0727 0 Td
(GI-cancer,)Tj
4.4731 0 Td
(lung)Tj
2.0069 0 Td
(cancer,)Tj
3.0727 0 Td
(pancreatic)Tj
4.3597 0 Td
(cancer,)Tj
3.067 0 Td
(prostate)Tj
3.4299 0 Td
(cancer,)Tj
3.0728 0 Td
(gynecological)Tj
5.6295 0 Td
(can-)Tj
-34.7978 -1.2983 Td
(cers,)Tj
2.0239 0 Td
(cholangiocarcinoma)Tj
8.3735 0 Td
(and)Tj
1.7291 0 Td
(head)Tj
2.1373 0 Td
(and)Tj
1.7291 0 Td
(neck)Tj
2.109 0 Td
(cancer\),)Tj
3.4129 0 Td
(25-OHD)Tj
3.77 0 Td
(level)Tj
2.0126 0 Td
(at)Tj
0.9525 0 Td
(baseline,)Tj
3.6566 0 Td
(survival)Tj
3.3392 0 Td
(time)Tj
-35.2457 -1.2983 Td
(\(13)Tj
2.0295 0 Td
(month,)Tj
3.1465 0 Td
(36)Tj
1.6837 0 Td
(months)Tj
3.2825 0 Td
(or)Tj
1.0999 0 Td
(more)Tj
2.3414 0 Td
(than)Tj
2.0296 0 Td
(6)Tj
0.6973 0 Td
(months)Tj
3.2825 0 Td
(after)Tj
2.0353 0 Td
(inclusion\))Tj
4.2519 0 Td
(and)Tj
1.7348 0 Td
(number)Tj
3.4186 0 Td
(of)Tj
1.0148 0 Td
(days)Tj
1.9955 0 Td
(in)Tj
1.0375 0 Td
(the)Tj
-35.0813 -1.3039 Td
(study.)Tj
2.6135 0 Td
(To)Tj
1.3379 0 Td
(the)Tj
1.4684 0 Td
(greatest)Tj
3.2995 0 Td
(possible)Tj
3.4072 0 Td
(extent,)Tj
2.9026 0 Td
(the)Tj
1.4684 0 Td
(matched)Tj
3.6737 0 Td
(treated)Tj
2.999 0 Td
(and)Tj
1.7291 0 Td
(untreated)Tj
4.0762 0 Td
(patients)Tj
3.3676 0 Td
(had)Tj
1.7064 0 Td
(the)Tj
1.4683 0 Td
(same)Tj
-35.5178 -1.2983 Td
(cancer)Tj
2.8402 0 Td
(type,)Tj
2.143 0 Td
(but)Tj
1.5534 0 Td
(in)Tj
1.0318 0 Td
(the)Tj
1.474 0 Td
(GI-cancer)Tj
4.2463 0 Td
(group)Tj
2.6135 0 Td
(a)Tj
0.652 0 Td
(treated)Tj
2.9933 0 Td
(patient)Tj
3.0104 0 Td
(with)Tj
1.9956 0 Td
(small)Tj
2.3301 0 Td
(bowel)Tj
2.5851 0 Td
(cancer)Tj
2.846 0 Td
(was)Tj
1.7008 0 Td
(matched)Tj
-34.0155 -1.2982 Td
(with)Tj
1.9955 0 Td
(an)Tj
1.2019 0 Td
(untreated)Tj
4.0762 0 Td
(patient)Tj
3.0047 0 Td
(with)Tj
1.9956 0 Td
(colon)Tj
2.4548 0 Td
(cancer,)Tj
3.067 0 Td
(and)Tj
1.7348 0 Td
(one)Tj
1.6951 0 Td
(patient)Tj
3.0104 0 Td
(in)Tj
1.0318 0 Td
(the)Tj
1.474 0 Td
(intervention)Tj
5.1761 0 Td
(group)Tj
2.6078 0 Td
(with)Tj
-34.5257 -1.2983 Td
(rectal)Tj
2.4151 0 Td
(cancer)Tj
2.8459 0 Td
(was)Tj
1.6951 0 Td
(matched)Tj
3.6794 0 Td
(with)Tj
1.9956 0 Td
(a)Tj
0.6519 0 Td
(control)Tj
3.1238 0 Td
(with)Tj
1.9956 0 Td
(esophageal)Tj
4.558 0 Td
(cancer.)Tj
ET
Q
q
1 j
1 J
0 w
11.9999 0 0 11.9999 200.0125 217.0204 cm
BT
/F0 1 Tf
1 TL
-0.0033 Tc
0 0 Td
(Data)Tj
2.3102 0 Td
(extraction)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 200.0125 200.0125 cm
BT
/F6 1 Tf
1 TL
-0.004 Tc
0 0 Td
(Patients)Tj
3.4072 0 Td
(with)Tj
2.0012 0 Td
(detected)Tj
3.566 0 Td
(vitamin)Tj
3.3052 0 Td
(D)Tj
0.9581 0 Td
(deficiency,)Tj
4.49 0 Td
(i.e.)Tj
1.3663 0 Td
(25-OHD)Tj
3.7701 0 Td
(levels)Tj
/F10 1 Tf
0 Tc
2.3754 0 Td
(<)Tj
/F6 1 Tf
-0.004 Tc
0.9921 0 Td
(75)Tj
1.1679 0 Td
(nmol/L)Tj
3.2144 0 Td
(according)Tj
4.1839 0 Td
(to)Tj
-34.7978 -1.3039 Td
(local)Tj
2.0749 0 Td
(guidelines,)Tj
4.5014 0 Td
(were)Tj
2.126 0 Td
(asked)Tj
2.4604 0 Td
(to)Tj
1.0261 0 Td
(participate)Tj
4.4731 0 Td
(in)Tj
1.0318 0 Td
(the)Tj
1.474 0 Td
(study.)Tj
2.6135 0 Td
(After)Tj
2.2847 0 Td
(inclusion)Tj
3.9175 0 Td
(the)Tj
1.4683 0 Td
(demographic)Tj
5.5049 0 Td
(data)Tj
-34.9566 -1.2982 Td
(regarding)Tj
4.0932 0 Td
(age,)Tj
1.7688 0 Td
(sex)Tj
1.4683 0 Td
(and)Tj
1.7291 0 Td
(type)Tj
1.9162 0 Td
(of)Tj
1.0148 0 Td
(cancer)Tj
2.846 0 Td
(were)Tj
2.1203 0 Td
(retrieved)Tj
3.7814 0 Td
(from)Tj
2.2053 0 Td
(the)Tj
1.4684 0 Td
(patients')Tj
3.5829 0 Td
(medical)Tj
3.3619 0 Td
(records)Tj
3.2088 0 Td
(and)Tj
-34.5654 -1.2983 Td
(levels)Tj
2.3754 0 Td
(of)Tj
1.0148 0 Td
(25-OHD,)Tj
3.9968 0 Td
(CRP)Tj
2.0636 0 Td
(and)Tj
1.7291 0 Td
(albumin)Tj
3.5717 0 Td
(at)Tj
0.9524 0 Td
(baseline)Tj
3.4299 0 Td
(were)Tj
2.1203 0 Td
(measured.)Tj
4.337 0 Td
(The)Tj
1.7801 0 Td
(levels)Tj
2.3754 0 Td
(of)Tj
1.0148 0 Td
(25-OHD)Tj
3.7758 0 Td
(in)Tj
-34.5371 -1.2983 Td
(serum)Tj
2.7212 0 Td
(were)Tj
2.126 0 Td
(analyzed)Tj
3.6963 0 Td
(by)Tj
1.1849 0 Td
(chemiluminescence)Tj
8.1184 0 Td
(immunoassay)Tj
5.7543 0 Td
(\(CLIA\))Tj
3.1237 0 Td
(on)Tj
1.2756 0 Td
(a)Tj
0.652 0 Td
(LIAISON-instrument)Tj
-28.6524 -1.3039 Td
(\(DiaSorin)Tj
4.1669 0 Td
(Inc,)Tj
1.7574 0 Td
(Stillwater,)Tj
4.1896 0 Td
(MN,)Tj
2.0749 0 Td
(USA,\))Tj
2.6816 0 Td
(with)Tj
1.9956 0 Td
(a)Tj
0.6519 0 Td
(detectable)Tj
4.2293 0 Td
(range)Tj
2.4605 0 Td
(of)Tj
1.0148 0 Td
(7.5175)Tj
3.3392 0 Td
(nmol/L,)Tj
3.4355 0 Td
(CV)Tj
1.5818 0 Td
(25%)Tj
2.4434 0 Td
(at)Tj
-36.0224 -1.2982 Td
(the)Tj
1.4683 0 Td
(Department)Tj
5.091 0 Td
(of)Tj
1.0148 0 Td
(Clinical)Tj
3.3165 0 Td
(Chemistry,)Tj
4.6318 0 Td
(Karolinska)Tj
4.5581 0 Td
(University)Tj
4.405 0 Td
(Hospital.)Tj
3.8437 0 Td
(Opioid)Tj
3.0501 0 Td
(dose,)Tj
2.2677 0 Td
(infections)Tj
-33.647 -1.2983 Td
(and)Tj
1.7234 0 Td
(ESAS)Tj
2.4208 0 Td
(QoL-score)Tj
4.4447 0 Td
(were)Tj
2.1203 0 Td
(recorded)Tj
3.787 0 Td
(at)Tj
0.9468 0 Td
(baseline,)Tj
3.651 0 Td
(and)Tj
1.7291 0 Td
(after)Tj
2.0296 0 Td
(1)Tj
0.6917 0 Td
(month)Tj
2.914 0 Td
(and)Tj
1.7291 0 Td
(3)Tj
0.6916 0 Td
(months)Tj
3.2769 0 Td
(\(for)Tj
1.7234 0 Td
(surviving)Tj
-33.8794 -1.3039 Td
(patients\).)Tj
3.9344 0 Td
(After)Tj
2.2847 0 Td
(3)Tj
0.6917 0 Td
(months)Tj
3.2825 0 Td
(the)Tj
1.474 0 Td
(25-OHD)Tj
3.77 0 Td
(levels,)Tj
2.6022 0 Td
(CRP,)Tj
2.2904 0 Td
(albumin)Tj
3.566 0 Td
(and)Tj
1.7291 0 Td
(S-calcium)Tj
4.1896 0 Td
(were)Tj
2.1259 0 Td
(monitored)Tj
-31.9405 -1.2983 Td
(again.)Tj
2.5908 0 Td
(Survival)Tj
3.4526 0 Td
(time)Tj
2.0296 0 Td
(was)Tj
1.7007 0 Td
(recorded.)Tj
ET
Q
q
1 j
1 J
0 w
576 737.1 m
36 737.1 l
36 737.6 l
576 737.6 l
f*
36 741.2598 107.1496 23.6976 re
W* n
q
107.0929 0 0 23.6409 36 741.3165 cm
q
/I0 Do
Q
Q
Q
q
0 0 612 792 re
W* n
1 j
1 J
0 w
7.9999 0 0 7.9999 447.6472 745.7952 cm
BT
/F0 1 Tf
1 TL
-0.005 Tc
0 0 Td
(Vitamin)Tj
3.5008 0 Td
(D)Tj
0.9283 0 Td
(in)Tj
0.978 0 Td
(palliative)Tj
4.0252 0 Td
(cancer)Tj
3.1677 0 Td
(patients)Tj
ET
Q
q
1 j
1 J
0 w
36 48.0002 m
576 48.0002 l
576 47.5002 l
36 47.5002 l
f*
0.83 0.64 0.02 0 k
81.5811 34.9228 m
237.8835 34.9228 l
h
f*
0 g
7.9999 0 0 7.9999 36 36 cm
BT
/F0 1 Tf
1 TL
-0.005 Tc
0 0 Td
(PLOS)Tj
2.8559 0 Td
(ONE)Tj
2.3669 0 Td
(|)Tj
0.83 0.64 0.02 0 k
0.4748 0 Td
(https://doi.or)Tj
5.4142 0 Td
(g/10.137)Tj
3.8198 0 Td
(1/journal.po)Tj
5.1236 0 Td
(ne.01842)Tj
4.089 0 Td
(08)Tj
0 g
2.0906 0 Td
(August)Tj
3.2882 0 Td
(31,)Tj
1.5874 0 Td
(2017)Tj
34.0302 0 Td
(3)Tj
0.7654 0 Td
(/)Tj
ET
endstream
endobj
63 0 obj
<>stream
endstream
endobj
64 0 obj
<>stream
endstream
endobj
65 0 obj
<>stream
endstream
endobj
66 0 obj
<>stream
endstream
endobj
67 0 obj
<>stream
BT
66.402 0 Td
(14)Tj
ET
Q
endstream
endobj
68 0 obj
<>/XObject<>>>/CropBox[0 0 612 792]/MediaBox[0 0 612 792]/Parent 12 0 R/Annots 69 0 R/Contents 70 0 R/TrimBox[0 0 612 792]>>
endobj
69 0 obj
[71 0 R 72 0 R 73 0 R 74 0 R 75 0 R 76 0 R 77 0 R]
endobj
71 0 obj
<>/Border[0 0 0]/Dest(Rpone.0184208.ref022)>>
endobj
72 0 obj
<>/Border[0 0 0]/Dest(Rpone.0184208.ref022)>>
endobj
73 0 obj
<>/Border[0 0 0]/Dest(Rpone.0184208.s001)>>
endobj
74 0 obj
<>/Border[0 0 0]/Dest(Rpone.0184208.ref023)>>
endobj
75 0 obj
<>/Border[0 0 0]/Dest(Rpone.0184208.ref008)>>
endobj
76 0 obj
<>/Border[0 0 0]/Dest(Rpone.0184208.g001)>>
endobj
77 0 obj
<>/Border[0 0 0]/A 78 0 R>>
endobj
78 0 obj
<>
endobj
70 0 obj
[79 0 R 80 0 R 81 0 R 82 0 R 83 0 R 84 0 R 85 0 R 86 0 R 87 0 R 88 0 R]
endobj
79 0 obj
<>stream
q
0.83 0.64 0.02 0 k
346.3937 667.3323 m
355.9181 667.3323 l
h
f*
489.9969 628.3276 m
499.4646 628.3276 l
h
f*
321.5622 563.3008 m
355.4646 563.3008 l
h
f*
485.1213 374.1732 m
494.6457 374.1732 l
h
f*
231.9307 94.9039 m
236.6929 94.9039 l
h
f*
272.2394 81.9213 m
291.7984 81.9213 l
h
f*
0 g
1 j
1 J
0 w
10 0 0 10 211.9748 707.4141 cm
BT
/F6 1 Tf
1 TL
-0.004 Tc
0 0 Td
(Infections)Tj
4.2292 0 Td
(were)Tj
2.1203 0 Td
(defined)Tj
3.2258 0 Td
(as)Tj
1.0148 0 Td
(the)Tj
1.4684 0 Td
(percentage)Tj
4.5524 0 Td
(of)Tj
1.0148 0 Td
(days)Tj
1.9955 0 Td
(with)Tj
1.9956 0 Td
(antibiotic)Tj
4.0422 0 Td
(treatment)Tj
4.1329 0 Td
(the)Tj
1.4683 0 Td
(month)Tj
-32.4564 -1.3039 Td
(before)Tj
2.7382 0 Td
(study)Tj
2.3924 0 Td
(inclusion.)Tj
4.1386 0 Td
(Opioid)Tj
3.0557 0 Td
(dose)Tj
2.0353 0 Td
(at)Tj
0.9524 0 Td
(the)Tj
1.474 0 Td
(day)Tj
1.6327 0 Td
(of)Tj
1.0148 0 Td
(inclusion)Tj
3.9175 0 Td
(was)Tj
1.7008 0 Td
(recorded)Tj
3.7927 0 Td
(and)Tj
1.7291 0 Td
(translated)Tj
4.1669 0 Td
(to)Tj
1.0262 0 Td
(the)Tj
-35.7673 -1.2982 Td
(corresponding)Tj
6.0604 0 Td
(fentanyl)Tj
3.4582 0 Td
(dose)Tj
2.0409 0 Td
(\()Tj
/F11 1 Tf
[()]TJ
/F6 1 Tf
(g/)Tj
1.8596 0 Td
(hour\).)Tj
2.7212 0 Td
(Self-assessed)Tj
5.2554 0 Td
(QoL)Tj
2.0126 0 Td
(was)Tj
1.7008 0 Td
(recorded)Tj
3.7927 0 Td
(with)Tj
1.9956 0 Td
(the)Tj
1.474 0 Td
(Edmonton)Tj
-32.3714 -1.2983 Td
(Symptom)Tj
4.1101 0 Td
(Assessment)Tj
4.8643 0 Td
(Scale)Tj
2.2223 0 Td
(\(ESAS\))Tj
3.1011 0 Td
([)Tj
0.83 0.64 0.02 0 k
(22)Tj
0 g
(],)Tj
2.0806 0 Td
(that)Tj
1.7745 0 Td
(is)Tj
0.8504 0 Td
(routinely)Tj
3.8664 0 Td
(monitored)Tj
4.4901 0 Td
(every)Tj
2.347 0 Td
(second)Tj
3.0104 0 Td
(week)Tj
2.245 0 Td
(in)Tj
1.0375 0 Td
(all)Tj
-35.9997 -1.2983 Td
(patients)Tj
3.3675 0 Td
(at)Tj
0.9524 0 Td
(ASIH)Tj
2.4888 0 Td
(L)Tj
/F11 1 Tf
[()]TJ
/F6 1 Tf
(ngbro)Tj
3.5887 0 Td
(Park.)Tj
2.3073 0 Td
(Using)Tj
2.5966 0 Td
(the)Tj
1.4683 0 Td
(ESAS)Tj
2.4264 0 Td
(scale)Tj
2.109 0 Td
(10)Tj
1.1679 0 Td
(different)Tj
3.6566 0 Td
(parameters)Tj
4.6772 0 Td
(are)Tj
1.4456 0 Td
(assessed,)Tj
-32.2523 -1.3039 Td
(where)Tj
2.6475 0 Td
(QoL)Tj
2.0126 0 Td
(is)Tj
0.8504 0 Td
(one)Tj
1.6951 0 Td
(such)Tj
2.0636 0 Td
(parameter.)Tj
4.5354 0 Td
(The)Tj
1.7858 0 Td
(ESAS-scale)Tj
4.6601 0 Td
(ranges)Tj
2.8233 0 Td
(from)Tj
2.2053 0 Td
(010,)Tj
2.3925 0 Td
(where)Tj
2.6475 0 Td
(the)Tj
1.474 0 Td
(number)Tj
3.4129 0 Td
(10)Tj
1.1736 0 Td
(is)Tj
-36.3796 -1.2982 Td
(the)Tj
1.4683 0 Td
(`worst)Tj
2.6645 0 Td
(possible)Tj
3.4129 0 Td
(quality)Tj
2.9537 0 Td
(of)Tj
1.0148 0 Td
(life')Tj
1.6611 0 Td
(and)Tj
1.7291 0 Td
(0)Tj
0.6973 0 Td
(represents)Tj
4.32 0 Td
(a)Tj
0.652 0 Td
(`good)Tj
2.4548 0 Td
(quality)Tj
2.9536 0 Td
(of)Tj
1.0148 0 Td
(life')Tj
1.6611 0 Td
([)Tj
0.83 0.64 0.02 0 k
(22)Tj
0 g
(].)Tj
-27.4618 -1.2983 Td
(Data)Tj
2.1259 0 Td
(from)Tj
2.2054 0 Td
(treated)Tj
2.999 0 Td
(individuals)Tj
4.6488 0 Td
(with)Tj
1.9956 0 Td
(a)Tj
0.6519 0 Td
(survival)Tj
3.3392 0 Td
(time)Tj
2.0296 0 Td
(of)Tj
1.0148 0 Td
(less)Tj
1.6101 0 Td
(than)Tj
2.0296 0 Td
(3)Tj
0.6916 0 Td
(months)Tj
3.2825 0 Td
(were)Tj
2.126 0 Td
(matched)Tj
3.6737 0 Td
(with)Tj
-35.6199 -1.3039 Td
(data)Tj
1.9105 0 Td
(from)Tj
2.2053 0 Td
(the)Tj
1.474 0 Td
(corresponding)Tj
6.0548 0 Td
(time)Tj
2.0296 0 Td
(before)Tj
2.7439 0 Td
(death)Tj
2.4264 0 Td
(for)Tj
1.389 0 Td
(untreated)Tj
4.0705 0 Td
(individuals,)Tj
4.8756 0 Td
(i.e.)Tj
1.3606 0 Td
(if)Tj
0.7767 0 Td
(the)Tj
1.4683 0 Td
(individual)Tj
-32.7852 -1.2983 Td
(lived)Tj
2.1316 0 Td
(for)Tj
1.3776 0 Td
(40)Tj
1.1622 0 Td
(days)Tj
1.9899 0 Td
(after)Tj
2.0296 0 Td
(inclusion,)Tj
4.1329 0 Td
(data)Tj
1.9105 0 Td
(from)Tj
2.194 0 Td
(the)Tj
1.4627 0 Td
(40)Tj
1.1622 0 Td
(last)Tj
1.5534 0 Td
(days)Tj
1.9899 0 Td
(in)Tj
1.0318 0 Td
(life)Tj
1.4343 0 Td
(of)Tj
1.0091 0 Td
(the)Tj
1.4627 0 Td
(untreated)Tj
4.0649 0 Td
(matched)Tj
3.668 0 Td
(con-)Tj
-35.7673 -1.2983 Td
(trol)Tj
1.644 0 Td
(were)Tj
2.1203 0 Td
(collected.)Tj
-2.5681 -1.3039 Td
(The)Tj
1.7858 0 Td
(raw)Tj
1.7064 0 Td
(data)Tj
1.9162 0 Td
(is)Tj
0.8504 0 Td
(available)Tj
3.6623 0 Td
(in)Tj
0.83 0.64 0.02 0 k
1.0375 0 Td
(S1)Tj
1.1736 0 Td
(Table)Tj
0 g
(.)Tj
2.6645 0 Td
(However,)Tj
4.0762 0 Td
(in)Tj
1.0375 0 Td
(accordance)Tj
4.7338 0 Td
(with)Tj
2.0013 0 Td
(the)Tj
1.4683 0 Td
(approved)Tj
3.9741 0 Td
(applica-)Tj
-33.2841 -1.2982 Td
(tions)Tj
2.1996 0 Td
(to)Tj
1.0261 0 Td
(the)Tj
1.4684 0 Td
(Regional)Tj
3.736 0 Td
(Ethical)Tj
2.982 0 Td
(Review)Tj
3.0955 0 Td
(Board)Tj
2.6418 0 Td
(we)Tj
1.3266 0 Td
(have)Tj
2.058 0 Td
(removed)Tj
3.7474 0 Td
(the)Tj
1.474 0 Td
(age)Tj
1.542 0 Td
(and)Tj
1.7291 0 Td
(some)Tj
2.3301 0 Td
(other)Tj
2.3471 0 Td
(personal)Tj
-33.7037 -1.2983 Td
(data)Tj
1.9105 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
1.474 0 Td
(included)Tj
3.7077 0 Td
(subjects)Tj
3.3788 0 Td
(from)Tj
2.2054 0 Td
(the)Tj
1.474 0 Td
(dataset)Tj
2.9934 0 Td
(to)Tj
1.0261 0 Td
(make)Tj
2.3924 0 Td
(it)Tj
0.7881 0 Td
(impossible)Tj
4.4957 0 Td
(to)Tj
1.0261 0 Td
(identify)Tj
3.2938 0 Td
(single)Tj
2.5342 0 Td
(patients.)Tj
ET
Q
q
1 j
1 J
0 w
11.9999 0 0 11.9999 200.0125 509.2724 cm
BT
/F0 1 Tf
1 TL
-0.0033 Tc
0 0 Td
(Statistical)Tj
4.4504 0 Td
(analysis)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 200.0125 492.2645 cm
BT
/F6 1 Tf
1 TL
-0.004 Tc
0 0 Td
(Statistical)Tj
4.0195 0 Td
(analyses)Tj
3.4865 0 Td
(were)Tj
2.1203 0 Td
(performed)Tj
4.4731 0 Td
(using)Tj
2.3867 0 Td
(Stata)Tj
2.16 0 Td
(v.)Tj
0.9014 0 Td
(13.1.)Tj
2.0977 0 Td
(Baseline)Tj
3.5036 0 Td
(characteristics)Tj
5.9017 0 Td
(for)Tj
1.3889 0 Td
(the)Tj
1.4684 0 Td
(two)Tj
-33.9078 -1.2982 Td
(groups)Tj
2.9706 0 Td
(were)Tj
2.1203 0 Td
(compared)Tj
4.2463 0 Td
(using)Tj
2.3868 0 Td
(paired)Tj
2.7609 0 Td
(t-test)Tj
2.2507 0 Td
(for)Tj
1.3833 0 Td
(continuous)Tj
4.7395 0 Td
(variables,)Tj
3.9458 0 Td
(McNemar's)Tj
4.8926 0 Td
(test)Tj
1.6044 0 Td
(for)Tj
1.3833 0 Td
(binary)Tj
-34.6845 -1.3039 Td
(variables)Tj
3.719 0 Td
(and)Tj
1.7291 0 Td
(Wilcoxon)Tj
4.1499 0 Td
(signed)Tj
2.812 0 Td
(rank)Tj
2.0692 0 Td
(test)Tj
1.6044 0 Td
(for)Tj
1.3833 0 Td
(number)Tj
3.8098 0 Td
(of)Tj
1.0148 0 Td
(days)Tj
2.0012 0 Td
(in)Tj
1.0318 0 Td
(the)Tj
1.474 0 Td
(study.)Tj
3.0047 0 Td
(CRP)Tj
2.0636 0 Td
(was)Tj
1.7008 0 Td
(log-trans-)Tj
-33.5676 -1.2983 Td
(formed)Tj
3.1577 0 Td
(due)Tj
1.6951 0 Td
(to)Tj
1.0262 0 Td
(skewness,)Tj
4.1045 0 Td
(before)Tj
2.7383 0 Td
(conducting)Tj
4.7621 0 Td
(the)Tj
1.4684 0 Td
(paired)Tj
2.7609 0 Td
(t-test.)Tj
2.4718 0 Td
(The)Tj
1.7858 0 Td
(paired)Tj
2.7609 0 Td
(t-test)Tj
2.2507 0 Td
(was)Tj
1.6951 0 Td
(also)Tj
1.7688 0 Td
(used)Tj
2.0637 0 Td
(to)Tj
-36.51 -1.2983 Td
(compare)Tj
3.7133 0 Td
(vitamin)Tj
3.3109 0 Td
(D)Tj
0.9581 0 Td
(levels)Tj
2.3754 0 Td
(between)Tj
3.5263 0 Td
(baseline)Tj
3.4299 0 Td
(and)Tj
1.7291 0 Td
(after)Tj
2.0352 0 Td
(three)Tj
2.2677 0 Td
(months)Tj
3.2825 0 Td
(in)Tj
1.0318 0 Td
(the)Tj
1.4741 0 Td
(vitamin)Tj
3.3051 0 Td
(D)Tj
0.9581 0 Td
(group,)Tj
-33.3975 -1.2982 Td
(among)Tj
2.9933 0 Td
(the)Tj
1.4684 0 Td
(23)Tj
1.1735 0 Td
(patients)Tj
3.3675 0 Td
(that)Tj
1.7802 0 Td
(have)Tj
2.0579 0 Td
(a)Tj
0.652 0 Td
(measured)Tj
4.1102 0 Td
(vitamin)Tj
3.3108 0 Td
(D)Tj
0.9525 0 Td
(level)Tj
2.0182 0 Td
(at)Tj
0.9525 0 Td
(both)Tj
2.0579 0 Td
(time)Tj
2.0296 0 Td
(points.)Tj
-27.7283 -1.3039 Td
(The)Tj
1.7858 0 Td
(comparisons)Tj
5.3347 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
1.4684 0 Td
(change)Tj
3.0444 0 Td
(from)Tj
2.2053 0 Td
(baseline)Tj
3.4299 0 Td
(in)Tj
1.0375 0 Td
(opioid)Tj
2.8119 0 Td
(dose,)Tj
2.2677 0 Td
(infections)Tj
4.1499 0 Td
(and)Tj
1.7292 0 Td
(quality)Tj
2.9593 0 Td
(of)Tj
1.0148 0 Td
(life)Tj
-35.4498 -1.2983 Td
(between)Tj
3.5262 0 Td
(the)Tj
1.4684 0 Td
(two)Tj
1.7121 0 Td
(groups)Tj
2.9707 0 Td
(were)Tj
2.1203 0 Td
(made)Tj
2.4264 0 Td
(using)Tj
2.3868 0 Td
(crude)Tj
2.4944 0 Td
(fixed)Tj
2.194 0 Td
(effects)Tj
2.727 0 Td
(linear)Tj
2.5058 0 Td
(regression,)Tj
4.5467 0 Td
(where)Tj
2.6476 0 Td
(the)Tj
1.474 0 Td
(fixed)Tj
-35.2004 -1.2983 Td
(effects)Tj
2.7155 0 Td
(take)Tj
1.8652 0 Td
(the)Tj
1.4627 0 Td
(matched)Tj
3.668 0 Td
(structure)Tj
3.8154 0 Td
(of)Tj
1.0035 0 Td
(the)Tj
1.4626 0 Td
(data)Tj
1.9106 0 Td
(into)Tj
1.8311 0 Td
(account.)Tj
3.6 0 Td
(Due)Tj
1.8992 0 Td
(to)Tj
1.0205 0 Td
(heteroscedasticity)Tj
7.302 0 Td
(and)Tj
1.7234 0 Td
(skew-)Tj
-35.2797 -1.3039 Td
(ness)Tj
1.9048 0 Td
(in)Tj
1.0262 0 Td
(the)Tj
1.457 0 Td
(outcome)Tj
3.719 0 Td
(variables,)Tj
3.9344 0 Td
(bias)Tj
1.7745 0 Td
(corrected)Tj
3.9798 0 Td
(and)Tj
1.7235 0 Td
(accelerated)Tj
4.6374 0 Td
(bootstrap)Tj
4.0139 0 Td
([)Tj
0.83 0.64 0.02 0 k
(23)Tj
0 g
(])Tj
1.8425 0 Td
(were)Tj
2.109 0 Td
(used)Tj
2.0522 0 Td
(to)Tj
1.0148 0 Td
(calcu-)Tj
-35.189 -1.2983 Td
(late)Tj
1.6214 0 Td
(95%)Tj
1.9275 0 Td
(confidence)Tj
4.6034 0 Td
(intervals)Tj
3.6227 0 Td
(for)Tj
1.3833 0 Td
(the)Tj
1.474 0 Td
(mean)Tj
2.4434 0 Td
(differences.)Tj
4.7906 0 Td
(Since)Tj
2.3584 0 Td
(there)Tj
2.2677 0 Td
(was)Tj
1.6951 0 Td
(an)Tj
1.2019 0 Td
(imbalance)Tj
-29.3894 -1.2982 Td
(concerning)Tj
4.7451 0 Td
(CRP)Tj
2.0636 0 Td
(between)Tj
3.532 0 Td
(the)Tj
1.4683 0 Td
(groups,)Tj
3.1918 0 Td
(an)Tj
1.2019 0 Td
(adjusted)Tj
3.5773 0 Td
(analysis)Tj
3.3278 0 Td
(was)Tj
1.7008 0 Td
(also)Tj
1.7688 0 Td
(made)Tj
2.4208 0 Td
(for)Tj
1.389 0 Td
(each)Tj
2.0296 0 Td
(crude)Tj
2.4944 0 Td
(com-)Tj
-34.9112 -1.3039 Td
(parison,)Tj
3.4525 0 Td
(using)Tj
2.3868 0 Td
(a)Tj
0.6519 0 Td
(log-transformed)Tj
6.7408 0 Td
(version)Tj
3.1521 0 Td
(of)Tj
1.0148 0 Td
(CRP)Tj
2.0636 0 Td
(as)Tj
1.0148 0 Td
(covariate.)Tj
ET
Q
q
1 j
1 J
0 w
11.9999 0 0 11.9999 200.0125 307.1055 cm
BT
/F0 1 Tf
1 TL
-0.0033 Tc
0 0 Td
(Ethical)Tj
3.1842 0 Td
(statement)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 200.0125 290.1543 cm
BT
/F6 1 Tf
1 TL
-0.004 Tc
0 0 Td
(The)Tj
1.7801 0 Td
(studies)Tj
2.9877 0 Td
(were)Tj
2.1203 0 Td
(approved)Tj
3.9741 0 Td
(by)Tj
1.1849 0 Td
(the)Tj
1.4684 0 Td
(Regional)Tj
3.7303 0 Td
(Ethical)Tj
2.9877 0 Td
(Review)Tj
3.0954 0 Td
(Board,)Tj
2.863 0 Td
(Stockholm,)Tj
4.7452 0 Td
(Sweden;)Tj
3.5319 0 Td
(Dnr:)Tj
-34.469 -1.3039 Td
(2015/776-31)Tj
5.1816 0 Td
(\(vitamin)Tj
3.6454 0 Td
(D)Tj
0.9581 0 Td
(treatment\))Tj
4.4787 0 Td
(and)Tj
1.7291 0 Td
(2014/455-31/4)Tj
5.9868 0 Td
(\(controls)Tj
3.821 0 Td
(without)Tj
3.3279 0 Td
(treatment\))Tj
4.4787 0 Td
(and)Tj
1.7291 0 Td
(was)Tj
-35.3364 -1.2982 Td
(performed)Tj
4.4673 0 Td
(in)Tj
1.0375 0 Td
(accordance)Tj
4.7338 0 Td
(with)Tj
2.0013 0 Td
(the)Tj
1.4683 0 Td
(declaration)Tj
4.6998 0 Td
(of)Tj
1.0148 0 Td
(Helsinki.)Tj
3.8211 0 Td
(Written)Tj
3.3959 0 Td
(informed)Tj
3.9741 0 Td
(consent)Tj
3.3279 0 Td
(was)Tj
-33.9418 -1.2983 Td
(obtained)Tj
3.7303 0 Td
(from)Tj
2.2054 0 Td
(all)Tj
1.1508 0 Td
(patients,)Tj
3.5887 0 Td
(both)Tj
2.0636 0 Td
(cases)Tj
2.2223 0 Td
(and)Tj
1.7291 0 Td
(controls,)Tj
3.7077 0 Td
(before)Tj
2.7383 0 Td
(inclusion)Tj
3.9174 0 Td
(in)Tj
1.0375 0 Td
(the)Tj
1.4683 0 Td
(studies.)Tj
3.2145 0 Td
(This)Tj
1.9843 0 Td
(con-)Tj
-34.7582 -1.3039 Td
(sent)Tj
1.8481 0 Td
(gave)Tj
2.0013 0 Td
(us)Tj
1.1055 0 Td
(the)Tj
1.4683 0 Td
(opportunity)Tj
5.04 0 Td
(to)Tj
1.0205 0 Td
(collect)Tj
2.7892 0 Td
(data)Tj
1.9162 0 Td
(retrospectively)Tj
6.0605 0 Td
(3)Tj
0.6973 0 Td
(months)Tj
3.2825 0 Td
(before)Tj
2.7382 0 Td
(inclusion)Tj
3.9175 0 Td
(and)Tj
1.7291 0 Td
(up)Tj
-35.6142 -1.2983 Td
(to)Tj
1.0261 0 Td
(one)Tj
1.6951 0 Td
(year)Tj
1.9049 0 Td
(after)Tj
2.0352 0 Td
(inclusion.)Tj
ET
Q
q
1 j
1 J
0 w
11.9999 0 0 11.9999 200.0125 195.9874 cm
BT
/F2 1 Tf
1 TL
-0.0033 Tc
0 0 Td
(Results)Tj
/F0 1 Tf
0 -1.4976 Td
(Demography)Tj
5.8772 0 Td
(of)Tj
1.0488 0 Td
(cases)Tj
2.8016 0 Td
(and)Tj
1.8661 0 Td
(controls)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 200.0125 161.0078 cm
BT
/F6 1 Tf
1 TL
-0.004 Tc
0 0 Td
(Fifty)Tj
2.0522 0 Td
(patients)Tj
3.3732 0 Td
(were)Tj
2.1203 0 Td
(included)Tj
3.7134 0 Td
(in)Tj
1.0318 0 Td
(the)Tj
1.474 0 Td
(vitamin)Tj
3.3052 0 Td
(D)Tj
0.9581 0 Td
(treated)Tj
2.999 0 Td
(group.)Tj
2.8346 0 Td
(Eight)Tj
2.3471 0 Td
(patients)Tj
3.3676 0 Td
(died)Tj
1.9672 0 Td
(within)Tj
2.8119 0 Td
(one)Tj
-34.3556 -1.2982 Td
(month)Tj
2.9196 0 Td
(of)Tj
1.0148 0 Td
(treatment,)Tj
4.3597 0 Td
(one)Tj
1.7007 0 Td
(patient)Tj
3.0048 0 Td
(did)Tj
1.5477 0 Td
(not)Tj
1.5703 0 Td
(take)Tj
1.8709 0 Td
(the)Tj
1.474 0 Td
(vitamin)Tj
3.3052 0 Td
(D)Tj
0.9581 0 Td
(oil)Tj
1.2416 0 Td
(and)Tj
1.7291 0 Td
(was)Tj
1.7008 0 Td
(excluded,)Tj
4.0081 0 Td
(and)Tj
1.7291 0 Td
(2)Tj
-34.1345 -1.3039 Td
(patients)Tj
3.3675 0 Td
(were)Tj
2.1203 0 Td
(lost)Tj
1.6327 0 Td
(to)Tj
1.0262 0 Td
(follow)Tj
2.6985 0 Td
(up)Tj
1.2643 0 Td
(since)Tj
2.245 0 Td
(they)Tj
1.9219 0 Td
(were)Tj
2.126 0 Td
(dismissed)Tj
4.1328 0 Td
(from)Tj
2.2054 0 Td
(the)Tj
1.474 0 Td
(Palliative)Tj
3.8494 0 Td
(Home)Tj
2.7383 0 Td
(Care)Tj
2.1089 0 Td
(Team.)Tj
-34.9112 -1.2983 Td
(Thirty-nine)Tj
4.8868 0 Td
(patients,)Tj
3.5944 0 Td
(18)Tj
1.1735 0 Td
(men)Tj
2.0069 0 Td
(and)Tj
1.7348 0 Td
(21)Tj
1.1679 0 Td
(women,)Tj
3.4299 0 Td
(survived)Tj
3.6056 0 Td
(more)Tj
2.3414 0 Td
(than)Tj
2.0296 0 Td
(1)Tj
0.6973 0 Td
(month)Tj
2.9197 0 Td
(and)Tj
1.7291 0 Td
(were)Tj
2.126 0 Td
(included)Tj
-33.4429 -1.2983 Td
(in)Tj
1.0318 0 Td
(the)Tj
1.474 0 Td
(final)Tj
2.0012 0 Td
(analysis)Tj
3.3279 0 Td
(and)Tj
1.7291 0 Td
(were)Tj
2.1203 0 Td
(thus)Tj
1.9389 0 Td
(matched)Tj
3.6736 0 Td
(with)Tj
1.9956 0 Td
(untreated)Tj
4.0762 0 Td
(patients)Tj
3.3676 0 Td
(from)Tj
2.2053 0 Td
(the)Tj
1.4683 0 Td
(previous)Tj
3.651 0 Td
(study)Tj
-34.0608 -1.3039 Td
(cohort)Tj
2.8516 0 Td
([)Tj
0.83 0.64 0.02 0 k
(8)Tj
0 g
(].)Tj
1.6044 0 Td
(Twenty-six)Tj
4.6828 0 Td
(patients)Tj
3.3675 0 Td
(survived)Tj
3.6113 0 Td
(more)Tj
2.3414 0 Td
(than)Tj
2.024 0 Td
(3)Tj
0.6973 0 Td
(months)Tj
3.2825 0 Td
(and)Tj
1.7291 0 Td
(could)Tj
2.4548 0 Td
(be)Tj
1.1509 0 Td
(included)Tj
3.7077 0 Td
(in)Tj
1.0374 0 Td
(the)Tj
1.4684 0 Td
(3)Tj
-36.0111 -1.2982 Td
(month)Tj
2.9196 0 Td
(follow)Tj
2.6986 0 Td
(up)Tj
1.2642 0 Td
(\()Tj
0.83 0.64 0.02 0 k
(Fig)Tj
1.8199 0 Td
(1)Tj
0 g
(\).)Tj
1.2642 0 Td
(The)Tj
1.7801 0 Td
(mean)Tj
2.4435 0 Td
(age)Tj
1.5477 0 Td
(was)Tj
1.6951 0 Td
(62)Tj
1.1735 0 Td
(years)Tj
2.2621 0 Td
(\(SD)Tj
1.7745 0 Td
(13\).)Tj
1.7347 0 Td
(All)Tj
1.4004 0 Td
(patients)Tj
3.3675 0 Td
(included)Tj
3.7077 0 Td
(in)Tj
1.0375 0 Td
(the)Tj
1.4683 0 Td
(study)Tj
ET
Q
q
1 j
1 J
0 w
576 737.1 m
36 737.1 l
36 737.6 l
576 737.6 l
f*
36 741.2598 107.1496 23.6976 re
W* n
q
107.0929 0 0 23.6409 36 741.3165 cm
q
/I0 Do
Q
Q
Q
q
0 0 612 792 re
W* n
1 j
1 J
0 w
7.9999 0 0 7.9999 447.6472 745.7952 cm
BT
/F0 1 Tf
1 TL
-0.005 Tc
0 0 Td
(Vitamin)Tj
3.5008 0 Td
(D)Tj
0.9283 0 Td
(in)Tj
0.978 0 Td
(palliative)Tj
4.0252 0 Td
(cancer)Tj
3.1677 0 Td
(patients)Tj
ET
Q
q
1 j
1 J
0 w
36 48.0002 m
576 48.0002 l
576 47.5002 l
36 47.5002 l
f*
0.83 0.64 0.02 0 k
81.5811 34.9228 m
237.8835 34.9228 l
h
f*
0 g
7.9999 0 0 7.9999 36 36 cm
BT
/F0 1 Tf
1 TL
-0.005 Tc
0 0 Td
(PLOS)Tj
2.8559 0 Td
(ONE)Tj
2.3669 0 Td
(|)Tj
0.83 0.64 0.02 0 k
0.4748 0 Td
(https://doi.or)Tj
5.4142 0 Td
(g/10.137)Tj
3.8198 0 Td
(1/journal.po)Tj
5.1236 0 Td
(ne.01842)Tj
4.089 0 Td
(08)Tj
0 g
2.0906 0 Td
(August)Tj
3.2882 0 Td
(31,)Tj
1.5874 0 Td
(2017)Tj
34.0302 0 Td
(4)Tj
0.7654 0 Td
(/)Tj
ET
endstream
endobj
80 0 obj
<>stream
endstream
endobj
81 0 obj
<>stream
endstream
endobj
82 0 obj
<>stream
endstream
endobj
83 0 obj
<>stream
endstream
endobj
84 0 obj
<>stream
endstream
endobj
85 0 obj
<>stream
endstream
endobj
86 0 obj
<>stream
endstream
endobj
87 0 obj
<>stream
endstream
endobj
88 0 obj
<>stream
BT
66.402 0 Td
(14)Tj
ET
Q
endstream
endobj
89 0 obj
<>/XObject<>>>/CropBox[0 0 612 792]/MediaBox[0 0 612 792]/Parent 12 0 R/Annots 91 0 R/Contents 92 0 R/TrimBox[0 0 612 792]>>
endobj
90 0 obj
<>stream
xyx6DPtj
%b(Th"*!hЊS&B$j)-N @'Iƚ}|9}g=}_zykz"P@(E"P@(E"P@(E"P@(E"P@(E"P@(E"P@(E"P@(E"P@(E"P@(E"P@(E"P@(E"P@(E.X0;mofHo"P@(E"P@k}$R@(EBg|_/}k_ڪ
-?Wog(E"P@(E#0ffH8:<-u|Em"P@(@>`?~sWg|aa.vw1JCxOA,E"P@(E"|_3SX_<4@zZ@(E"0?"]~O5> 1_/`M
Se@(E"P@(El
_-swR_B3T|"P@(;|ɇ[|3?O}Nl@;u(E"P@(E|WѰXwmE-|-űO[ܟ"P@(E>Cvd??'>Oq$MR4ҹ>>Ջ"P@(E"P@!j[xu7Ƿ|Yۓ*f>@(E"0oL
j]6{\} `2jnǛa"P@(E"P@0ӬkoxI]/zZ@(E"0WǟiT];!G َ'r)"P@(E"P@(kG do}:/rðFX$u(E"P
^O~'z>ؓ
}q7lPE"P@(E"P֎@{l53,zP?4l~bR"P@(Elg|v
^rTj4\g|1j;@(E"P@(E` KoroHx=y~]7q#E"Pv|`篏:l#ⳍK;"P@(E"Pʩ/k|3R_W_K2)l]@(ED߮Χϥgu}>v"P@(E"PD 4.._3Z']}W\p;"P@(o|9e䳭?U(E"P@(EKrWe}B{xo{k_赮uk"P@(E`!pk^¹ѺW@(E"P@(E`[#d08vE#X)u]v;Z@(E"U}["P@(E"P:F `ӐЅZwt
ox/l^K u]R@(EEi|FR_}kE"P@(Em :='}ߎ]owik_{c;Ρ-E"P@X8|yc>˷oϜ_@(E"P@;@f$cfw{H)߾ny|;7nxIK(E"Pcq{
np;X@(E"P@ R2#]{Γ7
}U(E"P_~ '{ov Ws(E"P@(E`A`PHu
=)И9O~1\|;P"P@XDN˵}ɧHBP}#[@(E"P@(@v5#m12S}cWۊ@(EU>(wd7j=/߾*n,E"P@(Eߞm|ՄË@(E폀O2ӏ4.߾@(E"P@(;!w "P@(;"P@(E"0o"P@(E`(߾uuT(E"P@(E\Mʷ_M ;"P@7ʷ[DjO(E"P@(E`'A|NY@(E`A|zZ@(E"P@+ʷU8jL(E"p(~1"P@(E"P@
ʷohR@(E39:"P@(E"(߾[@(Eo9^@(E"P@(;;<5"P@"Pۋg"P@(E"P(߾F*V@(E,
%R"P@(E"(߾Zw@(E]E"P@(E"C(߾C`E"PC|ö@(E"P@(E`3o8U@(E,"1j"P@(E"(߾X@(E)ۧh]@(E"P@(
NT@(Elʷo;K(E"P@(E P}^"P@(@E`/E"P@(E,(4p5"P@7L@(E"P@(E`"P}[E"PG|Ǽ3"P@(E"P ʷw"P@(,u"P@(E"(o_H"P@(E`o_#P+E"P@(Eo/ۿxV[(E"(߾CP@(E"P@(;'wθ"P@(8u"P@(E"0oԶ"P@(E`+(߾uH(E"P@(E\}ʷ_}"P@+ʷU8jL(E"P@(E`A|zZ@(E`'A|NY@(E"P@7ʷ[DjO(E"p5(~5"P@(E"P@:ʷonU@(E-645"P@(E"(߾[@(Eo ^@(E"P@(@yBm(E"Po6YUE"P@(E"vʷJ"P@(@S,E"P@(E?ʷ֣"P@(;9wP@(E"P@(;
;
[@(El#ʷo#`"P@(E"P6@ӻE"P!P}BV@(E"P@(#L٢I3vathofL'0܍,]=n9CTOfp`P,R}bZ@(E"P@(sr~>5$7~L%oQ|zLS_;pwSHС=.!
g'Sh§>F(Яh=&%INmj#koH@ii0^-ў'pAE"P@(EE@w|e̗S=hme%a
`aSh+զ$xC
Q4Ӄa#7CE
eh8)QB%F>J2j+A2<8tjxꖢ3
ʙ-/T `8&
QP*1F\ .SP疱6fB^Jcl2tQkjôMc<c|1̛:6
4d
Jz`
j%ã-jPbR6k{M[SXEFce=!&3$FRH8\ B,ƣ(t+c-)*7ҩt.i*6^X?!<+RVUX^{֔Pwc1KwV1ocD4د>#zʷ/bXks(E"P@(E`ȷ3_N(>AvZT
˿\r%^U.2(,bΈ2Kvhj
2dP"Qd4-FM-HCelPCoHK:Cx9
3 y3vFy(y NE[mGmCX25~X4"@㗆/(45ïU$uX&)>F28.gIdj3 7uf!ư֭a[c:pMGPПm]E AxK6),Oƍ-~
˘1fgkxM%5cj\UD0~\RdsΡMooVX0Ĵ##&xH^qؐ?a!}ز_' nj\<ޑ%~A K%SY˷Xב"P@(E"P\!o!fR}$T#0ַ/|;O:$9
#oK%LÊ
eE3ӯF$O /%Xi ILy20x?b QGm#xsO| \
(~ujkd\֩L-]%z^ u$du^?Ol\O?8eL2<@(=衁25@te3\m%?GEgxEu4DC;Sg>~K^
L?HPUj4@a0Vm[Ѡ*t4zCXgyUaa|Bҟ5{wk,xmҿ?s9V'裏V?iO{wi]p0Vپ*]o*(oy[>e@уTk:AI{ Ƃ" !N㑿u{4oZo.E"P@(E9A Fr7R}N"ȪT*6l@~/dōo|>P[XEZ'䘆˕n?\"5̨:F۲%2CȄ:K%*%L0{F77wWU1~*dQev3dx$ec(=ڱ!Stq6AS%S3KcG7~pY|s9GUTG(pN3Ufn_b
C-iCEp@*c[ӵFEszW#=??s?Ҹ@Uo,'b~wkpY3ͼ36P1Fڝ4*S+fZ%`9+SW46_<)mG٬AL4SU[[-_[nv|4@@7c-}xGv&7ey1qͨeyt@B@Tm`ʷ/VLkm(E"P@(E`!ȷQ5kgo_8n;#
0_~1飷C?C:0J`p:cP79%SdZt'ү*$u%]*cvSDkZ|뮻O5n{۾/Pp
xK)f45D(,1Q `,ΙOb).M,\NfHNCDC={{.nw;3rdP&o
4(wI.#3ͨX'%n:(ꇪ[]1eʰ6꩞pL$^I{ア,%`Gc4ˀa\E<
G&Bs|q6h$%gj6Ygu{3KB&tml#?#|0NnS
wBv?
8le]ט4u{ݛGGak Wx]FwEɟ 0MG0VÕbY FL53K=(5"P@(E"@aPy˩D0upP
+'|2yo_O|:pwX];lȷ++5dѬ.%m:F'Z/)UOUyxab.yc?Sv^/y4pcxX4vQ.g+]\=8esazհXbdbmf Yj"%FAc!CX,7S;l1w}w}w~^ĵb\lh0), j1LIsK?%TuTh֣ͥC!=6I86I2l#?lE%ѝ}%QrrS3tSa/)dtQrcN²,IS(M,)ڒb,ѣ,-:e.;mzֵ>G?٬wqf`i~c#=Vjnqi~GC?7NzX
;rc=ǐ>gyÆ
(S넒.z߾X1E"P@(E@ F?|9e?|Bq9(h.I;anoXbEvŢDq4B !%up,dm&dA?I@Ϙ⒰[CR#9 Lf-_?g(_i4Rby b͌j.#KV$c`hgbQРĩ@iS! ??Ñb:83p5
MGtN,*u/2<_a[L3jurw*QLa")T_F1[`ƍ%K;c|}EP{7/LJޥ5.i3E>2\ֈ/V̭Tj hڢBc#b8Wا(;̙a<.b$==g~k$]JF9%FuQV[b|bGh\jho"A@P]dRO V-)E"P@(E'm4̗Snpʷpo/Y(+ߎs(ü98 OxۍbaYc.c(
/wҏF:ϭ%tjD'%Ft4`Bkw
Y43|;%ߢymI35zcFEW8F'1
J[Fد6
j.5 FtBwذy28S1f4U
23hV